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 ABSTRACT 
 
 Kumba Vatham is one of the Vatha disease described in Yugi Vaithiya 
Chindamani 800. 
 
 This disease is correlated with periarthritis which is mentioned in medicine. 
 
 The disease is diagnosed by using Siddha parameters like “Envagai Thervugal, 
Kaalam, Thinai, Mukkutra Verupadugal and modern parameters like laboratory and 
radiological investigations. 
 
 20 patients of either sex has been selected, both as In patients and Out patients 
and they were administrated with the clinical trial drug. 
 
 Mukkirattai Chooranam – 2gm twice a day with hot water for 30 days. 
 
 The trial drug is subjected to biochemical and pharamacological analysis. At 
the end of the trial study majority of cases showed good clinical improvement. 
 
 
LIST OF ABBREVIATIONS 
 
 
%  - Percentage 
i.e.,   - That is 
RA  - Rheumatoid Arthritis 
ESR  - Erythrocyte Sedimentation Rate 
ECG  - Electro cardiogram 
gms  - Grams 
kg  - Kilogram 
mg  - Milligram 
dl  - Decilitre 
ml  - Milli litre 
cm  - Centimeter 
S E M   - Structural Equation Modelling 
ANOVA - Analysis Of Variance 
Hb  - Haemoglobin 
TC  - Total Count 
MCV  - Mean Corpuscular Volume 
DC  - Differential Count 
MCHC - Mean Corpuscular Haemolgobin Concentration 
P  - Polymorphs 
L  - Lymphocytes 
E  - Eosinophils 
WBC  - White Blood Corpuscles 
RBC  - Red Blood Corpuscles 
Ref  - Reference 
CT  - Computerized Tomography 
MRI  - Magnetic Resonance and Imaging 
JVP  - Jugular Venous Pulsation 
Bid  - Twice a day 
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CHAPTER-I 
INTRODUCTION 
 
  ‘fw;w FUthf;Fq; fhjypj;j thflKk; 
  gw;Wf; Nfhnyhd;Nw ghpfhuk; - Kw;w  
  mtd; nghWg;gy;yh nyhd;Wkhtjpy;iy 
nad;Nw ,tDzuf; fPHj;jp mq;F” 
 
 Siddha system of medicine is the oldest system of medicine in India.  It is of 
Dravidian origin and has it entire literatures in Tamil language. Its origin is also 
traced to mythological sources belonging to the shaivam. According to the tradition, 
Lord Shiva conveyed the knowledge of medicine to his wife Parvathi. 
 
 The knowledge was passed from her to Nandhi and finally it was given to the 
Siddhars. 
 
 This world and universe around it are made up of five basic elements 
(Panchaboothams) namely earth, water, fire, air and space. More over, 
panchabootham constitutes the arusuvaigal. So changes in the arusuvaigal may 
influences the diseases of the human body. These five elements combine to form three 
humours (Vatham, Pitham, Kapham).  According to Siddha, the human body 
composes of 96 thathuvam whose balance is very essential for the healthy human life. 
 
  ‘mz;lj;jpYs;sNj gpz;lk; 
  gpz;lj;jpYs;sNj mz;lk; 
  mz;lKk;> gpz;lKk; xd;Nw 
mwpe;J jhd; ghHf;Fk; NghNj” 
 
 In the normal human body all these three are in the homeostasis and exist in 
the ratio 1:1/2:1/4. Disharmony of this homeostasis may produce disease and called 
astrithudam as tridhosam. The three thathus are formed by the following way: 
 
 Vatham  Abanan + Idakalai 
Pitham   Pranan + Pinkalai 
Kapham  Samanan + Suzhumunai 
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 So, panchabootham, arusuvaigal, trithathus and human body are interrelated 
with each other so dishormany in any of the above may produce the disease. 
 
 More over mind influences the formation of many disease. Now-a-days there 
is to more stress and strain. So Siddhars has already advised to treat the body as well 
as the mind. 
 
 Vatha disease were classified into 10 types. 
 
 Kumba Vatham is one among the Vatha disease. It is correlated with 
periarthritis in modern medicine. The advantage and unique features of Siddha 
medicine is the removal of the root causes of the disease and effective, perfect remedy 
for mind and soul.  They have enumerated many ways that are to be followed to 
maintain the body without being affected by any disease, to maintain sound mind and 
to have disease free life are called “MARUNTHU”. 
 
 Medicine can be defined as that which removes distress and leads an 
individual to perfect happiness (heavenly bliss). Siddhars have utilized herbs, metals, 
minerals, mercury, red oxide, alkalis, acid and poisons.  
 
 It states that, 
 
 ‘NtH ghU jioghU kpQ;rpdf;fhy; nky;y nky;y 
 gw;g nre;J}uk; ghNu” 
 
Ref: mfj;jpaH itj;jpak; vz;gJ gjpndz; rpj;jH ghba rpy;yiuf;  
Nfhit. 
 
 First initiate the medication with roots and leafs of the herbs then later on use 
parpam and chendoorams. They have developed their particular way of diagnosing the 
disease by Envagai Thervugal. 
 
 So this study of ancient Siddha’s concept of Kumba Vatham and it’s treatment 
with herbal preparation is taken up for the detailed study in preparing this dissertation. 
 
 I have tried to formulate the methodology to treat this disease very carefully, 
to help the sufferers of Kumba Vatham in giving new modality of treatment. 
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CHAPTER-II 
 
AIM AND OBJECTIVES 
 
 Vatha diseases cripples many people from attending their daily routine work.  
As we are people belonging to medical world, we are very much worried about their 
health conditions. 
 
 So far a perfect and complete remedy for this diseases has not been arrived at.  
The purpose of the author is to elucidate a good medicine from ancient Siddha 
literatures and to create hope and faith in their treatment. The drug which is prepared 
for the diseases ‘Kumba Vatham’ is economically beneficial for all levels of people.  
It is so effective when compared with other system of medicines. 
 
 The open labelled randomized clinical trial drug is,   
 
 MUKKIRATTAI CHOORANAM (internal medicine) 
 
 Ref: Gunapadam Mooligai Mudhal Vagupu (Page No.780) 
 
OBJECTIVE 
 
i. To study the clinical course of the disease Kumba Vatham with keen 
observation on the aetiology, pathology, diagnosis, prognosis, 
complications by making use of siddha concept. 
ii. To expose the unique diagnostic methods mentioned by Siddha text. 
iii. To know the disease Kumba Vatham alters the normal conditions under 
the topic of Mukkutram, Poripulangal, 7 Udal kattukal and Envagai 
Thervugal. 
iv. To know the extent of correlation of aetiology, classification, signs and 
symptoms of Kumba Vatham in Siddha aspect with ‘Periarthritis’ in 
modern medical science. 
v. To have an idea about the incidence of the disease with age, sex, socio-
economic status, habit, family history and climatic conditions. 
vi. To study the effects of trial drugs for various stages of Kumba Vatham. 
vii. To evaluate the bio-chemical and pharmacological effects of the trial 
clinical medicine. 
viii. To have a plan for further extensive studies on this disease. 
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CHAPTER-III 
REVIEW OF LITERATURES 
 
a) SIDDHA ASPECTS 
 
There are 4448 diseases mentioned in Siddha system of medicine. Special 
attention have been given to these thiridhosam and there is a general assumption, that 
there are 80 Vatha diseases, 40 Pitha diseases and 20 Kapham diseases. 
 
‘vd;dNt thjkJ vz;gjhFk;” 
     - a+fp itj;jpa rpe;jhkzp-800 
 
and Kumba Vatham is one of the variety of Vatha disease. 
 
Among three vital humours, Vatham is placed as chief factor (as king) to be 
affected and leads derangement of other two factors named as Pitham and Kapham 
and they initiate the diseases.  
 
‘thjky;yhJ Nkdp nflhJ” 
 
This verse denotes Vatha is the root cause to bodly affliction. 
 
             ‘xOq;Fld; jNjo; %r;Nrhq;fp ,aq;f 
   vOr;rp ngw vg;gzpAkhw;w vOe;jphpa  
  Ntfk; Gyd;fSf;F Nktr; RWRWg;G 
   thfspf;Fk; khe;jHf;F thA” 
      - kUj;Jt jdpg;ghly; 
  
Function of Vayu / Vatham is mentioned in the above poem, as it provides 
functional energy and briskness to physical, mental and special senses for human. 
 
Though the three basic vital humours are the structural component of whole 
body they have their own seats in the body as it is dominant in such places. The poem 
below says the particular regions mostly influenced by Vatha. 
 
‘cz;b rikj;Jlw; $l;Lq;Flw;gFjp 
 jpz;bw nyd;G nrtpFwq;F - tpz;l 
njhLTzHT Njhw;Wtpf;Fk; - NjhypLg;gpy; thWk; 
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 tLtpyplkhk; tspf;F” 
      - kUj;Jt jdpg;ghly; 
 
Accordingly Vatham is originally placed in intestine, bone, thigh, skin, 
nervous system, joints and muscles etc., so derangement of Vatha produces 
pathological conditions such as, 
 
 Body pain & various type of pain – cly; Nehjy;> Fj;jy;> gpsj;jy; 
 Weakness of nervous function – euk;G Fd;wy;  
 Tremor – eLf;fk; 
 Rigidity - ,Wf;fkhjy; 
 Dryness of fluids – ePHg;girapd;ik (Including Synovial fluid) 
 Subluxation – iffhy; ,lk; tpl;Lg; ngauy; 
 Weakness of organs or functional units – cWg;Gj; jsHr;rp 
 Stiffness or numbness – cWg;Gf;fs; njhopyw;W kuk;Nghy; fplj;jy; 
 Constipation, oliguria – kyk;> rpWePH jPa;jy; 
 Bony pain – vYk;Gf;Fs; Jisg;gJ Nghd;w czHr;rp 
 Loss of function of extermities – iffhy; klf;fTk;> ePl;lTk; Kbahjgb 
nra;jy;. 
 Perverted taste and excessive salivation – vr;RitAk; JtHg;gha; ,Uj;jy; 
my;yJ JtHg;gha; tha; eP&Wjy; 
 
According to Siddha system, human is composed of 96 Thathuvangal as said 
earlier, they can be identified as physiological elements. Among them, physiological 
activities of the body are regulated by the three vital elements (or) humours and udal 
thathus. The three humours other wise called Uyir thathukkal (or) Thirithathukkal-
Vatham, Pitham and Kapham. 
 
‘kpfpDk;  FiwapDk; Neha; nra;Ak; E}NyhH 
tdpKjyh vz;zpa %d;W” 
     - jpUf;Fws; 
 
Udal thathus are: 
 
 Saaram - Lymph 
 Senneer - Blood 
 Oon - Muscle 
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 Kozhupu - Fat 
 Enbu - Bone 
 Moolai - Bone marrow 
 Sukkilam / Suronitham - Sperm and Ova. 
 
VATHAM: 
 
 Synonym: Vayu, Arasan, Air 
 
Definition: 
 
 Vatham (or) Vayu is not mere a wind, but it is that which causes motion, 
energy and sensation of every cell in the body.  So, Vatham is a humour which is 
responsible for constructive nature of works in the human body. 
 
Genesis of Vatha: 
 
 Vatham = vali + aagayam 
 
Vali bootham and aagaya bootham are combined to form Vatham. 
 
Genesis of vatha naadi: 
 
 During respiration abana vayu is combined with idakalai naadi.  Thus the 
Vatha humour is generated physiologically. 
 
 Vatha naadi = idakalai + abana vayu 
 
Aetiology of Vatha diseases: 
 
The  common etiological factor for all types of Vatha diseases including 
“Kumba Vatham” have been described generally in Yugi Vaidhya Chinthamani-800, 
Agasthiyar Kanma Kaandam-300 and Agasthiyar Gunavagadam. 
 
It is essential to know the disease, cause for the disease, also the nature of the 
patient, the degree of the illness, season and also the time of occurrence of the disease 
before treating the patient. This must to be considered. 
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In Yugi Vaidhya Chinthamani – 800: 
 
‘vd;dNt thje;jhndz;gjhFk; 
,fj;jpNy kdpjHfSf; nfa;JkhW  
gpd;dNt nghd;jidNa NrhuQ;nra;J 
nghpNahHfs; gpuhkiziuj; J}\dpj;Jk; 
td;d Nttr; nrhj;jpw; NrhuQ; nra;J 
khjh gpjh FUit kwe;j NgHf;Fk; 
fd;dNt Ntjj;ij epe;ij nra;j NgHf;Fq; 
fhaj;jpw; fye;jpLNk thje;jhNd” 
 
 Breach of trust.  
 Abusing the holy man. 
 Exploiting of the properties of charities. 
 Ingratitude towards mother, father and teachers and abusing holy. 
 Intake of food with bitter, astringent and pungent taste foods. 
 Intake of spoiled food.  
 Drinking of polluted rain water.   
 Day sleep.  
 Lifting over weight.  
 Excessive lust.  
 Disregarding the divinity.  
 Refusing food for clestitudes and sanyasingal. 
 Disregarding the advice of preceptors.  
 Involving in murdering, stealing, speaking lie.  
 Indulging in sexual act during vititation of Vatha.  
 Walking for a long distance.  
 Exposure to dampness, cold-eating.  
 Taking excessive curd immediately after eating vegetables and fruits 
causes toxic factors which affect bones and muscles. 
 
In Agasthiyar Kanma Kaandam – 300 
 
‘E}nyd;w thjk; te;j tifjhNdJ 
   Jz;ikaha;f; fd;kj;jpd; tifiaf; NfS 
fhypNy Njhd;wpaJ fLg;gNjJ 
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   iffhypy; Kof;fpaJ tPf;fkJ 
NfhypNy gLfpd;w tpUl;rkhd 
   Foe;ij kue;jid ntl;ly; Nky;Njhy;rPty; 
E}ypNy rPt[e;J fhy; Kwpj;jy; 
   ey;ynfhk;G  jioKwpj;jy; eypj;jy; jhNd” 
      - mfj;jpaH fd;kfhz;lk; 
        (ghly; vz;.56> gf;fk; vz;.23) 
 
 Removing the bark of living trees. 
 Breaking the legs of living animals. 
 Cutting the branches removing leaves. 
 
In Agasthiar Gunavagadam: 
 
‘njhy;iy nra;a ,d;Wk; ntF thj Neha;fs;  
njhy;Yyfpy; khe;jpUf;Fr; fhz;gJz;L  
vy;iyapy;iy thjNeha; Neh;ik jd;ik  
,ay;ghf mwpe;jplNt tpguq;NfNs” 
 
‘tpguklh mrjp rd;dp %is NehT  
tphpthd %isaJ kpUJthfp  
mtdpjdpy; %j;jpuf; Fz;bf;fha; tpahjpahYk;  
jtKdpth; jPh;fhf;if NkfNuhfk;  
jd;ikAs;s Kj;jz;Lf; nfhb tpahjp  
mtkpyhg; ghpr euk;gOj;jq; fz;lha;”  
‘mZFklh khkprj;jpd; tpahjpahYk;  
mg;gNd #jfj;jpd; ngUf;fhYk;  
Fzkpy;yh ,urk; tq;fk; jpd;dyhYk;  
FbnfLj;j thjkJ cz;ghkg;gh”  
- mfj;jpah; Fzthflk; 
 
 Brain diseases.  
 Renal disorders.  
 Sexually transmitted diseases.  
 Diseases of the vertebral and spinal cord.  
 Menorrhagia.  
 Taking improperly prepared medicine of mercury and lead. 
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Causes according to Astrology: 
 
 ‘$Wnkhd;W %d;Wld; FyT ehiye;NjhopDk; 
  Fw;wkhk; eyj;jpDk; nfh^uk; gz;zpuz;bYk; 
 NruNt Gjd; jhDNkh rPhpak;kid epd;wpoy; 
  nrg;nghdhj jPiknahL nra;Agr;re;jhDk; 
 neLe;Jf;f kpf;fthk; elf;Fe;jhJ njhopy; jhk; 
  epe;ijahFq; fPy;gpbg;G ePLnka;apy; Njhd;Wkhk; 
 fhhpaq;fs; Nrkjhq; fy;taJ FiwAkhk; 
  fz;LzHe;J fzpjty;Nyhd; fUj;Jld; nrg;gpdhNuh” 
      - kzp ke;jpu itj;jpa Nrfuk; 
         Ref: Heritage of the Tamils Siddha medicine 
 
 Certain position of planets of certain period of human life will produce 
keelpidippu and causes sequlare of Vatha vitiation. 
 
 All the above causes described from various texts are the major causes for the 
derangement of Vatham. 
 
CLINICAL FEATURE FOR “KUMBA VATHAM:”  
  
 in Yugi Vaithiya Chinthamani,  
 
‘etpypNt Njhz;kPJq; fuj;jpd; kPJk;  
eype;jnkj;j thfpNa erTz; lhFk; 
ftpyhNt fd;dnkhL eade; jhDq; 
fLj;JNk tpWtpWg;G nkhpTq; fhZk;  
JtpypNt Jbg;ghFq; rpuR jd;dpw;  
Row;wpNa ehgpf;fPo; typA Kz;lhk;  
mtpyNt mb ehf;fpy; mod;W fhZk;  
kyUNk tUFk;g thje; jhNd” 
    - a+fp itj;jpa rpe;jhkzp-800 
 
 Pain in the shoulder joints and upper limbs.  
 Burning and tingling sensation over the cheek and eyes. 
 Twitching over the scalp.  
 Pain in the hypogastrium.  
 Glossitis. 
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‘jhndd;w frg;NghJ JtHg;Giug;G 
rhjfkha; kpQ;RfpDQ; rikj;j tz;zk; 
Mndd;w thwpdJ nghrpj;jyhYk; 
Mfhaj; NjwyJ Fbj;jyhYk; 
ghndd;w gfYwf;f kpuhtpopg;G 
gl;bdpna kpfTWjy; ghunka;jy; 
Njndd;w nkhopahH Nkw; rpe;ijahfpy; 
rPf;fpukha; thjkJ nrdpf;Fk; jhNd” 
    - a+fp itj;jpa rpe;jhkzp-800 
 
Also stated in Yugi Vaidhiya Chinthamani, that imbalance diet like increased 
taste of bitter, sour, hot and rotten meals starvation, inappropriate habits and disturbed 
mind readily affect Vatha and causes disease. 
 
‘tspjU fha; fpoq;F tiutpyh japyy; Nfhio 
Kdp japH Nghd; kpLf;F Kiwapyh Tz;b Nfhly; 
FspHjU tspapw;NwfLq;Fdpg;Gw Tyty; ngz;bH  
fspjU Kaf;fk; ngw;NwhH fb nray; fUtpahkhy;” 
      - rghgjp ifNaL 
 
In Sabapathy manuscript, Excess intake of carbohydrate diet, curd, 
inappropriate diet, exposure to cold, increased sexual action will disturb Vatha & thus 
cause Vatha diseases. 
 
‘ghhpdpw; gag;gl;lhYk; gyUld; Nfhgpj;jhYk; 
fhnudf; fUfpNahbf; fOkuj;Juj;jpdhYk; 
VH ngW jdJ neQ;rpd; kpfj;Jf;fkile;jpl;lhYk;  
ghhpa fhw;wpdhYk; glhpDk; thjq;fhZk;” 
      - guuhr Nrfuk; 
 
The book of Pararaja Sekarama denotes, mental afflictions such as fear, anger, 
sorrow and excess manual work like running, climatical changes also causes 
disturbances of Vatham. 
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Qualities of Vatham: 
 
 Own qualities-6 
 
 Vatha is dry  - twl;rp    
 Vatha is cold  - FspHr;rp 
 Vatha is subtl  - mZj;Jtk; 
 Vatha is rough  - fbdk; 
 Vatha is Unstabl - mirjy; 
 Vatha is light  - ,yF 
 
 
 Opposite qualities - 6 
 
 Unctuous - gRik 
 Hot  - mf;fpdp 
 Solid  - nfl;b 
 Soft  - kpUJ 
 Stabl  - ];jpuk; 
 Heavy  - gST 
 
Vatham Types:  
 
 Piranan  
 Abanan  
 Viyanan  
 Udhanan  
 Samanan  
 Nagan  
 Koorman  
 Kirukaran  
 Devathathan  
 Dhananjeyan 
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Functions of Vatham: 
 
Sl. 
No. 
VATHAM GENERAL FEATURES 
CHANGES IN 
KUMBA 
VATHAM 
1. 
Piranan 
(Uyir Kaal) 
Responsible for respiration and  
digestion. 
Normal 
2. 
Abanan 
(Kizhnokkumkaal) 
Responsible for voiding of urine, 
stools, semen, menstrual flow. 
Normal 
3. Udhanan 
It is responsible for the reflex actions 
like vomiting, hiccough, cough etc. 
Normal 
4. 
Viyanan 
(Paravukaal) 
Found in extension and flexion of the 
parts of the body and helps in 
distribution of the nutrients to various 
parts of the body. 
Affected 
5. 
Samanan 
(Nadukkaal) 
Transfers nutrients to each and every 
organ. 
Affected 
6. Nagan Helps in opening & closing of eyelids. Normal 
7. Koorman 
Responsible for vision, lacrimation 
and yawning. 
Normal 
8. Kirugaran 
Induces appetite,and all secretions in 
the body including nasal secretion and 
sneezing. 
Normal 
9. Thevathathan 
Induces and stimulates a person to 
become alert, get anger, to quarrel, to 
sleep etc. 
Affected 
10. Dhananjeyan 
Resides in the cranium and produces 
bloating of the body after death. This 
leaves from the body after 3 days of 
death, forming a way through the 
skull. 
---- 
 
In Kumba Vatham, Viyanan, Samanan, Thevathathan will be mainly 
affected. 
 
Exaggeration of Vatham: 
 
 Body weakness and darkness. 
 Shivering. 
 Abdominal distension. 
 Constipation. 
 Insomnia. 
  Liking to eat hot foods. 
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 Immunity. 
 Giddiness. 
 
Diminition of Vatham: 
           
 Body ache. 
 Hoarseness of voice. 
 Loss of memory.   
 Altered consciousness. 
 Sleep disturbances.  
 Anorexia. 
 Paleness & coolness of body. 
 Excessive salivation. 
 Heaviness of body. 
 
 The functions of other two humours are discussed below: 
 
FUNTIONS OF PITHAM:  
 
Pitham is functionally divided into five types. They are: 
 
Sl. 
No. 
PITHAM NORMAL FEATURES 
CHANGES IN 
KUMBA VATHAM 
1.  Anala Pitham  Helps in appetite and  
digestion. 
Normal  
2.  Ranjaga Pitham  
Maintains colour and 
contents of blood.  
Normal  
3.  Sathaga Pitham  
Controls the whole body and 
responsible for fulfiling a 
purpose. 
Affected  
4.  Prasaga Pitham  
Dwells in the skin and 
concerned with the shine, 
glow, texture and its 
complexion.  
Normal  
5.  Alosaga Pitham  Vision. Normal  
 
In Kumba Vatham, Sathaga Pitham is mainly affected. 
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FUNCTIONS OF KAPHAM:  
 
It is of five types. They are: 
 
Sl. 
No. 
KAPHAM GENERAL FEARTURES 
CHANGES IN 
KUMBA 
VATHAM 
1.  Avalambagam  
Controls the heart and 
circulatory system.  
Normal  
2.  Kilethagam  
Moistens, softens the food 
and helps to be digested.  
Normal  
3.  Pothagam  Sensory perception of taste.  Normal  
4.  Tharpagam  
Responsible for the coolness 
of the eyes, sometimes may 
be referred to as 
cerebrospinal fluid.  
Normal  
5.  Santhigam  
Necessary for the lubrication 
and the free movements of 
joints.  
Affected  
 
In Kumba Vatham, Santhigam is affected. 
 
UDAL THATHUKKAL (SEVEN PHYSICAL CONSTITUENTS): 
Sl. 
No. 
UDAL 
THATHUKKAL  
GENERAL 
FEARTURES 
CHANGES IN 
KUMBA VATHAM 
1.  
Saaram  
(Digestive essence)  
Responsible for the 
growth & development. 
Normal  
2.  Senneer (Blood)  
Responsible for the 
colour of blood and  
nourishment of the body. 
Normal  
3.  Oon (Muscle)  
Gives contour to the body 
which is needed for the 
physical activity. 
Affected  
4.  Kozhuppu (Fat)  
Lubricates the organs to 
facilitate frictionless 
functions. 
Normal  
5.  Enbu (Bones)  
Supports & protects the 
vital organs. 
Affected  
6.  
Moolai  
(Bone marrow)  
Nourishes the bone 
marrow. 
Normal  
7.  
Sukkilam / 
Suronitham  
Responsible for 
reproduction  
-  
 
 Derangement of Vatham leads to vitiation of Pitham and Kapham leading to 
disturbances in Udal Thathukkal. 
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 The Other factors responsible for derangement of three vital humours and 
Udal Thathukkal are discussed below: 
 
THINAI (LAND): 
  
The geographical distribution of the land is classified into five regions: 
 
1. Kurinchi - Mountain and its surroundings, causes Kapha noigal 
2. Mullai  - Forest and its adjacent area, causes Pitha, Vatha noigal  
3. Marudham - Fertile fields and its surroundings, safest place  
4. Neidhal - Sea and its surroundings, Vatha diseases are common 
   here. 
5. Paalai   - Desert and its surroundings, Vatha, Pitha, Kapha  
   diseases are common 
 
 The above features are described clearly in Thanvanthiri Naadi as, 
 
 ‘FwpQ;rp epyNk thjkhq; $Wk; ghiy gpj;jkhQ; 
 nrwpe;j kUje; rpNyj;kkjhQ; rpNyj;k thj Ky;iyajhk; 
 epiwe;j nea;jy; thj gpj;jk; epyq;f sjid kaf;fhap 
 Yiwj;j tpahjp fe;jpUf;f Kgha kwpe;J nra;tPNu” 
      - jd;te;jphp ehb 
 
KAALA MARUBADUGAL: PARUVAKALAM (SEASONS)  
 
Sl. 
No. 
KAALAM KUTTRAM 
STATE OF 
KUTTRAM 
SUVAI 
1.  
Kaar Kaalam Aavani & 
Purattasi 16
th
 August  To 
15
th
 October 
VATHAM-  
PITHAM-  
Vettrunilai 
Vazharchi, Thanilai 
Vazharchi  
Enippu, 
Pulippu,  
Uppu 
2.  
Koothir Kaalam Iypasi & 
Karthigai  
16
th
 October To  
15
th
 December  
VATHAM-  
PITHAM-  
Thanilai Vazharchi, 
Vettrunilai 
Vazharchi  
Enippu,  
Kaippu,  
Thuvarppu 
3.  
Munpani Kaalam  
Margazhi & Thai  
16
th
 December To  
15
th
 February  
PITHAM- 
Thannilai  
Adaithal  
Enippu, 
Pulippu,  
Uppu 
4.  
Pinpani Kaalam Masi & 
Panguni   
16
th
 February To  
15
th
 June  
KAPHAM  
Thannilai 
Vazharchi  
Enippu, 
Pulippu,  
Thuvarppu 
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5.  
Elavenir Kaalam Chithirai 
& Vaikaasi 16
th
 April To 
15
th
 June 
KAPHAM  
Vettrunilai 
Vazharchi  
Kaippu, 
kaarppu  
Thuvarppu 
6.  
Mudhuvenir Kaalam  
Aani & Aadi  
16
th
 June To 15
th
 August 
VATHAM  
KAPHAM  
Thannilai 
Vazharchi  
Thannilai Adaithal  
Enippu  
 
 
UDAL VANMAI: 
 
 It means strength and vitality of the body and classified into 3 types. 
 
1. Eyarkai vanmai - Inherited immunity 
2. Kala vanmai - Immunity occurred by Age, season & time 
3. Cheyarkai vankai - Improvement of 3 vitality obtained by diet  
(jpdrhp) day-to-day habits and physical 
exercise. 
 
 Any modifications in Udal Vanmai leads to diseases. 
 
NOI KANIPPU VIVADHAM (Differential Diagnosis): 
 
Resembling the symptoms of Kumba Vatham are mentioned here: 
 
1. Sagana vatham: 
 
 ‘NfSNk fOj;jpd; fPoiuf;F NkYk; 
  Nfbahd fukpuz;L kpfNt nehe;J 
 thSNk rhPunky;yhq; fdj;jpUf;Fk; 
  thypgHf;F kdq;fz;Z kaf;fkhFk; 
 VSNk ,uz;L fz;Zk; vhpr;rYz;lhk; 
  Vw;wkha; kye;jhDk; ,Wfpf; fhZk; 
 NjSNk nfhl;bdJ Nghw; fLf;Fk; 
  Nrfd thjj;jpdple; jPHfe;jhNd” 
     - a+fp itj;jpa rpe;jhkzp-800 
 
 Neck pain. 
 Radiating pain to the shoulders and upper limb. 
 Heaviness of the body. 
 Mental depression. 
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 Giddiness. 
 Burning sensation in the eyes. 
 Constipation. 
 
2. Paanikambavatham: 
  
 ‘khHf;fkha; tha;Tkha;........................ 
 eLf;fkha; ifapuz;Le; jpkpU Kz;lhk; 
 ............................ JzHr;rpaw;W 
 ghzp fk;gthjj;jpd; ghq;FjhNd” 
     - a+fp itj;jpa rpe;jhkzp-800 
 
 Tingling sensation numbness of upper limbs. 
 Tremor of upper limbs. 
 
Noi Nadal Noi Muthal Nadal 
 
 Diagnostic methods adopted in Siddha system of medicine are given below.  
 
 a). Piniyari Muraimai it based on following principles: 
1. Poriyal arithal 
2. Pulanal arithal 
3. Vinathal 
 
“Pori and Pulan are the five organs of perceptions and their senses 
respectively. Nose – smell, Tongue – taste, Eyes – vision, Ears & Skin – auditory & 
touch.  Porigal of patient and Doctors‟ are used by the physician as instruments. 
 
Vinathal is a method of enquiring about the details of patient‟s problem from 
his own words or from their attendant. 
 
The above mentioned principles can be compared to that of Interrogation 
(Vinathal) and Inspection (Poriyal arithal), Auscultation, Percussion & Palpation 
(Pulanal arithal). 
 
The important method adopted to diagnose the disease is by means of 
“Envagai Theruvagal”. 
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 ‘ehb ];ghprk; eh epwk; nkhop tpop 
 kyk; %j;jpukpit kUj;JtuhAjk;” 
 
 It is considered to be physician‟s instrument and this can be understand by 
following stanza: 
 
  ‘njhLf;fYw;W ml;l tpjg; ghPl;ir jd;id 
  Jyf;fKWk; gz;bjNu njspthfg; 
  gFf;fhpa ehbia eP gpbj;Jg; ghU 
  gfHfpd;w thHj;ij ghH ehitg; ghU 
  tFf;fhpa Njfnkd;wj; njhl;Lg; ghU 
  tskhd rhPuj;jpd; epwj;ijg; ghU 
  rfpf;fhpa kyj;ijg; ghH ryj;ijg; ghU 
  rhHe;j tpop jidg; ghHj;J njsptha; fhNz” 
      - mfj;jpaH itj;jpa ty;yhjp-600 
 
 
Envagai Thervugal Constitutes: 
 
 Nadi, Sparisam, Naa, Niram, Mozhi, Vizhi, Malam, Mootharam. 
 
 The fact regarding Envagai Thervugal suggests that it is mostly used as a 
diagnostic standard in Siddha system and more concentration should be given to get 
proficient knowledge. 
 
Naadi (Pulse): 
 
 According to Agathiyar Naadi, 
   
  ‘fhpKf dbia tho;jpf;  
   ifjdpy; ehb ghHf;fpy; 
  ngUtpu yq;F yj;jpy; 
   gpbj;jb eLNt njhl;lhy; 
  xUtpu Nyhby; thjk;  
   capHeL tpuypw; gpj;jk; 
  jpUtpuy; %d;wp Nyhby; 
   rpNyj;Jk ehb jhNd” 
     - mfj;jpaH ehb 
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 ngUtpuy; gf;fkhf kzpf;fl;Lf;F xU mq;Fyj;jpw;F Nky; Miu 
vd;gpd; NkNyhLk; ehb euk;G ,uj;jf;Fohapd; Nky; %d;W tpuy;fis itj;J 
rw;W mOj;jpAk;> jsHj;jpAk; ghHf;f Ms;fhl;b tpuyhfpa Kjy; tpuypy; 
czHj;JtJ thjk; vdTk;> eLtpuypy; czHj;JtJ gpj;jk; vdTk; ngsj;jpu 
tpuypy; czHj;JtJ fgk; vdTk; mwpaTk;. 
 
  ‘mwpe;JghH thjNk jdpj;j jhdhy; 
  md;dk; Nghy; elf;Fkg;gh ehb ghU 
  rhpe;jplNt fhy; Klf;Fk; NghJ fhl;Lk;” 
      - mfj;jpaH uj;jpd RUf;fk; 
 
 
 This poem says, Vitiated Vatha causes difficultly in walking (or) impaired 
function of lower extremities.  The examination of Naadi has been recognised as one 
of the principle means of Diagnosis and prognosis of disease from times immemorial. 
 
Sparisam (Skin): 
 
 Skin examination can be made out by inspection and touch. It reveals 
warmness / chillness / dry / weeping skin / rough / smooth / soft / hard, tenderness or 
presence of ulcers, swelling, wrinkles, hair, pigmentation etc.,  
 
  ‘miwe;Njhk; thj NuhfpAly; 
  Mow;fz; KfKk; gy; kyKk; 
  epiwe;j tpopapy; ePH tbAk; 
  ePz;l ehT fWj;jplTk; 
  epiwe;j Ks;sha; jhdpUf;Fk; 
  ciwe;j ePuhy; fUfUj;J 
  Kiwaha; Nuhfk; cz;lhNk” 
 
Naa (Tongue): 
 
 The colour, character and condition of the tongue changes according to the 
changes in Mukkutram. 
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Niram (Colour complexion): 
 
 As Vatham is root cause for Vatham the colour of the patient‟s skin, tooth, 
etc., would be dark or black in colour. 
 
Mozhi (Speech): 
 
 Speech in Vatha patients may vary according to deranged dhosam and grade 
of the disease. 
 
Vizhi (Eye): 
 
 In this disease condition, both motor and sensory disturbances of the eye can 
be expected. 
 
 Burning of the eyes, lacrimation, irritation, colour changes are also noticed 
under this group. 
 
 Mostly in Kumba Vatham the eyes become dark and smoky in colour. 
 
 
Malam (Stools): 
 
 In Vatha diseases stools would be black in colour with constipation. 
 
Moothiram (Urine): 
 
 According to Agasthiyar Naadi, 
 
  ‘ciwe;j ePUq; fUfUj;J 
  Kiwaha; NuhfK Kz;lhNk” 
     - mfj;jpaH ehb 
 
 In Vatha disease, the colour of urine would be black leading to various 
diseases. 
 
Neer kuri: 
 
 Niram  - Denote the colour of the urine voided 
 Manam - Denote the smell of the urine 
 Edai  - Denote the specific gravity of the urine 
 Nurai  - Denote the frothy nature of the urine voided 
 Enjal  - Indicates the quantity of the urine voided 
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Nei kuri: 
 
 The method of Nei Kuri is described in Theriyar Venba as, 
 
  ‘mUe;JkhwpujKk; mtpNuhjkha; 
  mf;fy; myHjy; mfhyt+z; jtpHj;jow; 
  Fw;wstUe;jp cwq;fp itfiw 
  Mbf; fyrj; jhtp NafhJ nga; 
  njhU K$Hj;jf; fiyf;Fl;gL ePhpd; 
  epwf;Fwp nea;f;Fwp ep&gpj;jy; flNd” 
      - NjiuaH ntz;gh 
 
Method: 
 
 Prior to the day of urine examination, the patient is advised to take balanced 
diet and the quantity of food must be proportionate to his or her appetite and he or she 
should have had a good sleep. After waking up in the morning, urine voided first, is 
collected in a glass container and is subjected to analysis within 1 ½ hours.  A drop of 
gingelly oil is dropped without shake. The nature of the Nei kuri should be noticed in 
direct sunlight. 
 
Character of different Neer: 
 
 ‘muntd ePz;bbd ‡Nj thjk;” 
 
 When drop of oil spreads like a snake, it indicates Vatha neer, 
 
 ‘MopNghw; gutpd; m‡Nj gpj;jk;” 
 
If the drop of oil remains as that of ring it indicates Pitha neer. 
 
‘Kj;njhj;J epw;fpd; nkhoptjd; fgNk” 
 
If the drop of oil remains as that of pearl it indicates Kapha neer. 
 
Along with above mentioned eight types of examination another few 
principles in Siddha medicine are there. Man is composed of 5 elements like universe. 
 
‘mz;lj;jpYs;sNj gpz;lk; 
gpz;lj;jpYs;sNj mz;lk; 
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mz;lKk;> gpz;lKk; xd;Nw 
mwpe;Jjhd; ghHf;Fk; NghNj” 
   - rl;lKdp epfz;L 
 
Time, place, nature of the body (Pirakiruthi) and environmental changes have 
inter relations among them. 
 
So, besides Envagai Thervugal, Parva Kalangaal and Thinnai also should be 
taken in consideration to arrive at perfect and correct diagnosis. 
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b) MODERN ASPECT 
 
INTRODUCTION: 
 
JOINTS: 
 
 The place of union or junction between two (or) more bones of the skeleton, 
especially a junction that admit more (or) less motion of one (or) more bones is 
formed termed as a joint. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 SOLID JOINTS (Non-synovial joints), are termed synarthroses and are 
commonly grouped according to the principle types of interosseous connective tissue, 
into fibrous joint and cartilaginous joints. Synarthroses of both types, are 
characterised by almost all the cranial junction and their respective derivations and the 
desmocranium and chronologicranium cavitated (synovial) joints are formaly termed 
diarthroses and with few exceptions (the tea mandibular joints and those involving the 
clavi are between the ends (or) other circum scribe surface of endochondrial bones. 
 
JOINTS 
(Articulation / Junction) 
Solid joints Caritated jonts 
Cartilagenous 
joints 
Fibrous joints 
Synovial 
joints 
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GENERAL CLASSIFICATION OF SYNOVIAL JOINTS: 
 
1. Plane joints. 
2. Ginglymi (hinge) joints. 
3. Trochoid (pivot) joints. 
4. Spheroidal joints (Ball and socket). 
5. Bicondylar joints. 
6. Ellipsoid joints. 
7. Sellar (saddle) joints. 
 
PERIARTICULAR DISORDERS OF THE EXTREMITIES: 
 
 A number of periarticular disorders have become increasingly common, due in 
part to greater participation in recreational sports by individuals of a wide range of 
ages. Periarticular disorders most commonly affect the knee (or) shoulder. 
 
SHOULDER JOINT: 
 
 Made up of three bones, they are: 
  
i) Clavicle (Collar bone). 
ii) Hamerus (Upper arm bone). 
iii) Scapula (Shoulder blade), 
 
 as well as associated muscles, ligaments and tendons. The articulation between 
the bones of the shoulder make up the shoulder joints. “Shoulder joint”, typically 
which is the major joint of the “shoulder”. But can more broadly include the 
acromioclavicular joint.  In human anatomy, the shoulder joint comprises the part of 
the body where the humerus attaches to the scapula, the head sitting in the glenoid. 
 
 The shoulder must be mobile enough dor the wide range of the arms hands, 
but also stable enough to allow for action such as lifting and pulling. 
i) Clavicle (Collar bone): 
 
 The clavicle (or) collar bone is a flat bones that serves as a structure between 
the scapula and the sternum.  It is the only long bone in the body that lies horizontally.  
It makes up part of the shoulder and the pectoral girdle and is palpable in all people. 
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ii) Humerus (Upper arm bone): 
 
 It‟s nearly hemispherical in form.  It is directed upward, medial and a little 
backward and articulates with the glenoid cavity of the scapula to form the 
glenohumeral joint (Shoulder joint). 
 
iii) Scapula (Shoulder blade): 
 
 Also known as shoulder blade.  It is a triangular, flat bone of the shoulder 
girdle that articulates with the head of humerus at the glenohumeral joint, which is 
popularly called as shoulder joint. 
 
JOINTS OF SHOULDER: 
 
i) Sternoclavicular Joint. 
ii) Glenohumeral Joint. 
iii) Acromioclavicular Joint. 
 
i) Sternoclavicular joint: 
 
 This joint is formed by medial end of the clavicle with the manubrium (or) top 
most portion of the sternum. The costo clavicular ligament is the main stabilizer of the 
of the joint.  The sternoclavicular joint is the sole connection between the axial 
skeleton and the upper extremity.   
  
ii) Acromio clavicular joint: 
 
 The acromio clavicular joint is the sole joint of acromion, clavicle and scapula.  
The joint is diarthrodial joint itself has a little movement. It is held together by it‟s 
joint capsule and the coracoacromial ligaments. 
 
iii) Glenohumeral joint: 
 
 The glenohumeral joint is ball and socket synovial joint formed by the 
articular surface of the glenoid cavity and the head of the humerus.  It is the main joint 
of the shoulder and allows the arm to rotate in a circular fashion (or) to hinge out and 
up away from the body.  Shoulder joint is very mobile because glenoid fossa is 
shallow but this also adds to instability of the shoulder.  
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LIGAMENTS OF SHOULDER JOINT: 
 
i) Coracoclavicular ligament. 
ii) Glenohumeral ligament. 
a). Superior 
b). Middle 
c). Inferior  
iii) Coracohumeral ligament. 
 
i) Coracoclaviacular ligament: 
 
 Two coracoclavicular ligaments are, 
 
 a). Conoid 
 b). Trapezoid 
 
 which maintain the articulation of the clavicle with the coracoid process of the 
scapula. It is primary resistant to superior and posterior acromioclavicular dislocation. 
 
ii) Glenohumeral ligament: 
 
 Superior glenohumeral ligament has a variable origin on lateral aspect of 
scapula and inserts on the humerus near the lesser tubercle. Middle glenohumeral 
ligament originates from the laburm and inserts on the humerus, medial to the lesser 
tubercle. 
 
 Inferior glenohumeral ligament originates from the labrum and the adjacent 
glenoid neck, inserts on the anatomical neck of the humerus. 
 
iii) Coracohumeral ligament: 
 
 The coracohumeral ligament originates on the base and lateral border of the 
coracoid process of the scapula and inserts on the greater tubercle. 
 
NEUROVASCULAR SUPPLY: 
 
 Arterial supply to the glenohumeral joint is via the anterior and posterior 
circumflex humeralarteries and the suprascapular arteries.  Branches from these 
arteries form an anastamotic network around the joint. 
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MOVEMENTS: 
 
 As a ball and socket synovial joint, wide range of movement or 
permitted. 
 Extension (upper limb backwards in sagittal plane). 
 Flexion (upper limb forwards in sagittal plane). 
 Abduction (upper limb away from midline in coronal plane). 
 Adduction (upper limb towards midline in coronal plane). 
 Medical rotation (Rotation towards the midline, so that the thumb is 
pointing medially). 
 Lateral rotation (Rotation away from the midline, so that the thumb is 
pointing laterally). 
 
MOBILITY AND STABILITY: 
 
 The shoulder joint is one of the most mobile in the body, at the expense of 
stability. Here, we shall consider the factors that permit movement and those that 
contribute towards joint structure. 
 
PERIARTHRITIS 
 
Introduction: 
 
 „Periarthritis‟ also called frozen shoulder (or) adhesive capsulitis of shoulder, 
is a chronic inflammatory disorder of the shoulder and surrounding of the soft tissues.  
This condition is frequently caused by injury, leading to pain and lack of use.  As the 
joint becomes progressively lighter and stiffer, simple movements, such as raising the 
arm, becomes difficult.  If inflammation occurs with the capsule itself, the shoulder 
bones are unable to move with in the joint.  In some instances, the patients may be 
unable to move the shoulder at all. 
 
The definition, also defined by Lundberg, is: 
- Shoulder joint elevation of ≤135° 
- Restriction of motion is localised to the glenohumeral joint 
-  History, clinical and radiological examination show no other explanation 
 
 
 
 
 
28 
 
EPIDEMIOLOGY: 
 
 The incidence of periarthritis is approximately 3 per cent in the general 
population. Occurrence is rare in children and people under 40 but peaks between 40 
and 70 years of age. At least in its idiopathic form, the condition is much more 
common in women than in men (70% of patients are women aged 40–60). Frozen 
shoulder is more frequent in diabetic patients and is more severe and more protracted 
than in the non-diabetic population. Vaccine-related shoulder injuries (SIRVA) are 
increasing. 
 
CLASSIFICATION: 
 
 As in all situations where not all facts are known, many different ways of 
classifying may exist. 
 
 Perhaps it is wise to use the initial classification of Lundberg (1969): 
 
  - Primary periarthritis 
  - Secondary periarthritis  
 
  But not even this is clear – these groups need to be subdivided: 
 
  -  Primary periarthritis - Diabetic 
      - No other explanation 
   -  Secondary periarthritis - Post-traumatic 
      - Iatrogenic 
      - Other  
 
 There exists, of course, other types of classification.  In some, the diabetic 
periarthritis is a secondary type.  The secondary may be divided into extrinsic (causes 
outside the joint) and intrinsic (causes inside the joint). 
 
RISK FACTORS AND CAUSES: 
 A risk factor is something that elevates the risk of developing a disease or 
condition. For example, smoking is a risk factor for cancer - it elevates the risk of 
developing lung cancer.  
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Common risk factors are: 
 Age - being over 40 years of age.  
 Gender – common in women.  
 Recent surgery or arm fracture- immobility of recovery may cause the 
shoulder capsule to stiffen.  
 Chondral lesions, avascular necrosis or tendon injuries.   
 Scarring following traumatic tissue injury. 
 Diabetes - two to four times more likely to develop periarthritis for unknown 
reasons; symptoms may be more severe.  
 Having suffered a stroke.  
 Hyperthyroidism (overactive thyroid).  
 Hypothyroidism (underactive thyroid).  
 Cardiovascular disease (heart disease).  
 Parkinson's disease.  
 Tonic seizures 
 Accidents 
 Lung disease 
 Connective tissue diseases 
 Rheumatoid arthritis 
 Highly active antiretroviral therapy (HAART). 
 After breast and lung surgery 
 May have an autoimmune component. 
 Hypertriglyceridemia, 
 CVA with upper-extremity paresis, 
 Brachial plexus injuries. 
 Idiopathic frozen shoulder  
 Cervical spinal cord injury, and  
 Parkinson disease. 
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SIGNS AND SYMPTOMS: 
 
The most pervasive sign or symptom is; 
 
 A persistently painful and stiff shoulder joint.  
 Severe pain and sleep deprivation for prolonged periods due to pain that gets 
worse when lying still and restricted movement/positions.  
 The condition can lead to depression, problems in the neck and back, and 
severe weight loss due to long-term lack of deep sleep.  
 People who suffer from periarthritis may have extreme difficulty 
concentrating, working, or performing daily life activities for extended periods 
of time. 
 
 Signs and symptoms of periarthritis develop gradually; usually in three stages 
in which signs and symptoms worsen gradually and resolve within a two - year 
period.  
 
STAGES OF PERIARTHRITIS: 
 
There are three stages of periarthritis,  
 
 Painful stage or freezing stage - The freezing stage shows an insidious onset 
where pain is dominating the clinical picture.  Quite often, subacromial 
impingement is initially suspected because of the involvement of the 
subacromial bursa.  At the end of this period range of motion becomes limited 
in the typical way and diagnosis is usually no longer a problem. The shoulder 
becomes stiff and then very painful with movement. Movement becomes 
limited. Pain typically worsens at night.  
 Frozen/adhesive stage - the shoulder becomes increasingly stiff, severely 
limiting range of motion. Pain may not diminish, but it does not usually 
worsen.  
 Thawing stage - The thawing includes successive reestablishment of normal 
or near normal range of motion. Movement in the shoulder begins to improve. 
Pain may fade, but occasionally recur.  
 
 However, this time plane is an approximation of the most common time 
course of this disease.  It may vary greatly between different patients. 
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PATHOGENESIS: 
 
There are three different modalities of outcome following primary FS: 
 
-  40% restore the range of motion (ROM) and are pain free 
-  45% regain functional ROM but show residual symptoms 
-  15% show persisting stiffness with marked handicap (Noel et al 2000,  
    Shaffer et al 1992).  
 
 In frozen shoulder, there is a lack of synovial fluid, which normally helps the 
shoulder joint, a ball and socket joint, move by lubricating the gap between the 
humerus (upper arm bone) and the socket in the shoulder blade. The shoulder capsule 
thickens, swells, and tightens due to bands of scar tissue (adhesions) that have formed 
inside the capsule. As a result, there is less room in the joint for the humerus, making 
movement of the shoulder stiff and painful. This restricted space between the capsule 
and ball of the humerus distinguishes periarthritis from a less complicated, painful, 
stiff shoulder. 
 
 Dupuytren‟s disease is again shown to be related to PA.  Dupuytren‟s disease 
is significantly more common than usual among male relatives to FS patients and the 
microscopic changes in the anterior capsule and coracohumeral ligament are very 
similar to those in Dupuytren‟s disease of the hand (Bunker & Anthony 1995, Smith 
et al 2001). They show that half of the patients with FS also show signs of 
Dupuytren‟s!  Similarities with Dupuytren‟s are also shown when analysing the 
fibrotic capsule for cytokines and proteinases (Bunker et al 2000). 
 
 Pathoanatomically there is an involvement of the capsule in the glenohumeral 
joint.  The capsule volume is reduced and this is the cause for the restricted range of 
motion (Itoi & Tabata 1992).   
 
Diabetes and its relationship to periarthritis: 
 
• The incidence of periarthritis is two to four times higher in diabetics than 
in the general population. 
• The prevalence of diabetes in patients with periarthritis was 38.6%, 
whereby the total prevalence of a diabetic condition in patients with 
periarthritis was 71.5% 
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• Shoulder arthritis is common in type I and type II diabetic patients.  
 
 However, it is associated with age in type I and II diabetic patients and with 
the duration of diabetes in type I patients. 
 
Possible aetiology: 
 
 Diabetics have a higher incidence of periarthritis, probably because poor 
circulation leads to abnormal collagen repair and degenerative changes. The theory is 
that platelet derived growth factor is released from abnormal or ischemic blood 
vessels, which will then act as a stimulus to local myofibroblast proliferation. What 
follows has been proposed that microvascular disease, abnormalities of collagen 
repair and predisposition to infection may link diabetes with frozen shoulder. 
 
NATURAL COURSE: 
 
 Primary periarthritis is usually considered to be a self limiting disease which 
usually lasts for 18-24 months but will usually heal with minor residual handicap. 
 
Examination: 
 
 Currently the diagnosis of primary periarthritis is based on the findings of the 
patient history and physical examination. 
 
 The following outcome measures have been used in studies researching 
periarthritis. 
 
 Shoulder Pain and Disability Index (SPADI)  
 Disability of the Arm, Shoulder and Hand scale  
 American Shoulder and Elbow Surgeons Standardized Shoulder Assessment 
Form (ASES)  
 Simple Shoulder Test (SST)  
 Penn Shoulder Scale (PSS)  
 NPRS  
 VAS  
 SF-36  
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 In a recent systematic review, the psychometric properties of the SPADI, 
DASH, ASES and SST were examined. Reliability, construct validity and 
responsiveness were all found to be favourable for various shoulder pathologies but 
the review did not address their strength relative to adhesive capsulitis specifically.  
 
Observation of Posture and Positioning: 
 
 Scapular winging of the involved shoulder may be viewable from the 
posterior and/or lateral views. 
 
Screen: Upper Quarter Exam (UQE) & Neuro Screen (dermatomes, myotomes, 
reflexes)  
 
 A full UQE should be performed to rule out cervical spine involvement or any 
neurological pathologies.  
 
ROM Screen: Active/Passive/Overpressure: 
 
 Cervical, Thoracic, Shoulder ROMs with OP as well as rib mobility should be 
performed.  
 
 Scapular substitution frequently accompanies active shoulder motion.  
 
Resisted muscle tests: 
 
 Shoulder External Rotation (ER)/ Internal Rotation (IR) / Abduction 
(ABd) (seated) should be performed.  
 
 Patients with adhesive capsulitis present with weakness in shoulder ER, IR 
and ABd relative to the uninvolved side.  
 
Formal ROM: Active/Passive/Overpressure  
 
 Shoulder Flex/ABd/ER/IR: 
 
 The method of measuring ER and IR ROM in patients with suspected 
periarthritis varies in the literature.  
 Patients with periarthritis commonly present with ROM restrictions in 
a capsular pattern. A capsular pattern is a proportional motion 
restriction unique to every joint that indicates irritation of the entire 
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joint. The shoulder joint has a capsular pattern where external rotation 
is more limited than abduction which is more limited than internal 
rotation (ER limitations > ABD limitations > IR limitations). In the 
case of periarthritis, ER is significantly limited when compared to IR 
and ABD, while ABD and IR were not seen to be different.  
 
Joint Accessory Mobility: 
 
 Glenohumeral joint:  
 
 Anterior   
 Inferior  
 Posterior  
 Posterior Capsule Stretch  
 
 In patients with periarthritis, the anterior and inferior capsule will be the most 
limited but joint mobility will be restricted in all directions. 
  
Special tests: 
 
 Yang et al. investigated the reliability of three function-related tests in patients 
with shoulder pathologies via a non-experimental study (See Resources for scoring 
guide): 
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Hand-to-neck: 
 
 Shoulder flexion + abduction + ER  
 Similar to ADLs like combing hair, putting on a necklace  
 
Hand-to-scapula: 
 
 Shoulder extension + adduction + IR  
 Similar to ADLs like getting into back pocket  
 
Hand-to-opposite scapula:  
 
 Shoulder flexion + horizontal Adduction  
 
 
 Reliability of the three tests was excellent, ranging from 0.83-0.9. Correlation 
between the three was moderate (r=0.64 to 0.66).  
 
 These functional measures appear to be helpful for their objectivity in 
measuring shoulder dysfunction. However, even though the test battery is believed to 
be comprised of movements fundamental to activities of daily living, the direct 
relationship between these tests and activities of daily living cannot be assumed.  
 
Other tests:   
 
 No specific clinical test for periarthritis has been reported in the literature and 
there remains no gold standard to diagnose periarthritis. While there are no confirmed 
diagnostic criteria, a recent study determined a set of clinical identifiers that achieved 
consensus among 70 experts in the field for the first or early stage of primary 
(idiopathic) periarthritis. The following are tools that can be used to help determine 
the stage of periarthritis and/or irritability status.  
 
 Consensus was achieved on eight clinical identifiers clustered into two 
discrete domains (pain and movement) as well as an age component.  
 
1) Pain:  
 
 Strong component of night pain  
 Pain with rapid or unguarded movement  
 Discomfort lying on the affected shoulder  
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 Pain easily aggravated by movement  
 
2) Movement: 
 
 Global loss of active and passive ROM  
 Pain at end-range in all directions  
 
3) ONSET > 35 years of age  
 
 
DIAGNOSIS: 
 
 One sign of a periarthritis is that the joint becomes so tight and stiff that it is 
nearly impossible to carry out simple movements, such as raising the arm. The 
movement that is most severely inhibited is external rotation of the shoulder. 
             
 People complain that the stiffness and pain worsen at night. Pain due to 
periarthritis is usually dull or aching. It can be worsened with attempted motion, or if 
bumped. Periarthritis can be diagnosed if limits to the active range of motion (range 
of motion from active use of muscles) are the same or almost the same as the limits to 
the passive range of motion (range of motion from a person manipulating the arm and 
shoulder). An arthrogram or an MRI scan may confirm the diagnosis, though in 
practice this is rarely required. 
 
MRI and ultrasound: 
 
 Imaging features of adhesive capsulitis are seen on non-contrast MRI, though 
MR arthrography and invasive arthroscopy are more accurate in diagnosis. Ultrasound 
and MRI can help in diagnosis by assessing the coracohumeral ligament, with a width 
of greater than 3 mm being 60% sensitive and 95% specific for the diagnosis. The 
condition can also be associated with oedema or fluid at the rotator interval, a space in 
the shoulder joint normally containing fat between the supraspinatus and 
subscapularis tendons, medial to the rotator cuff. Shoulders with adhesive capsulitis 
also characteristically fibrose and thicken at the axillary pouch and rotator interval, 
best seen as dark signal on T1 sequences with oedema and inflammation on T2 
sequences. A finding on ultrasound associated with adhesive capsulitis is hypoechoic 
material surrounding the long head of the biceps tendon at the rotator interval, 
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reflecting fibrosis. In the painful stage, such hypoechoic material may demonstrate 
increased vascularity with Doppler ultrasound. 
 
DIFFERENTIAL DIAGNOSIS: 
 
 Some conditions can present with similar impairments and should be included 
in the clinician‟s differential diagnosis. These include, but are not limited to, 
osteoarthritis, acute calcific bursitis/tendinitis, rotator cuff pathologies, parsonage-
Turner syndrome, a locked posterior dislocation, or a proximal humeral fracture.   
 
Osteoarthritis (OA): 
 
 Both may have limited abduction and external rotation AROM but with OA, 
PROM will not be limited. Also, OA will have the most limitations with flexion while 
this is the motion that is least affected in adhesive capsulitis. Radiography have been 
used to rule out pathology of osseous structures. 
 
Bursitis: 
 
 Bursitis presents very similarly to adhesive capsulitis, especially compared to 
the early phases of frozen shoulder. Patients with bursitis will present with a non-
traumatic onset of severe pain with most motions being painful. A main difference 
will be the amount of PROM achieved with adhesive capsulitis being extremely 
limited and painful while bursitis will, while still painful, have larger ranges. 
 
Parsonage -Turner Syndrome (PTS): 
 
 PTS occurs due to inflammation of the brachial plexus. Patients will present 
without a history of trauma and with painful restrictions of all motions. The pain with 
PTS usually subsides much quicker than with adhesive capsulitis, and patients 
eventually display neurological problems (atrophy of muscles or weakness) that are 
seen several weeks after initial onset of pain. 
 
Rotator Cuff (RC) Pathologies: 
 
 The primary way to distinguish RC pathologies from adhesive capsulitis is to 
examine the specific ROM restrictions. Adhesive capsulitis presents with restrictions 
in the capsular pattern while RC involvement typically does not. RC tendinopathy 
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may present similarly to the first stage of adhesive capsulitis because there is limited 
loss of external rotation and strength tests may be normal. MRI and ultrasonography 
can be used to identify soft tissue abnormalities of the soft tissue and labrum.  
 
Posterior Dislocation: 
 
 A posteriorly dislocated shoulder can present with shoulder pain and limited 
ROM but, unlike adhesive capsulitis, started with a specific traumatic event. If the 
patient is unable to fully supinate the arm while flexing the shoulder, the clinician 
should suspect a posterior dislocation. 
 
PREVENTION: 
 
 To prevent the problem, a common recommendation is to keep the shoulder 
joint fully moving to prevent a frozen shoulder. Often a shoulder will hurt when it 
begins to freeze. Because pain discourages movement, further development of 
adhesions that restrict movement will occur unless the joint continues to move full 
range in all directions (adduction, abduction, flexion, rotation, and extension).  
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CHAPTER-IV 
 
MATERIALS AND METHODS 
 
INTRODUCTION 
 
 An open labelled randomized clinical trial to evaluate the therapeutic efficacy 
of the Siddha formulation MUKKIRATTAI CHOORANAM (internal) for the 
treatment of KUMBA VATHAM (Periarthritis) in shoulder joint. 
 
DATA COLLECTION 
 
 Siddha texts & literatures  
 Medical journals 
 Internet 
 Modern medicine text books 
 
TRIAL SPOT 
 
 The entire study was conducted on Out patients and In patients department of 
Government Siddha Medical College and Hospital, Palayamkottai. 
 
STUDY POPULATION 
 
 Periarthritis develop above the age of 30 years.  Found to be approximately 
3.4% adults in the general population. 
 
 Inclusion and exclusion criteria were mentioned below. 
 
Inclusion criteria: 
 
 Age: 30 – 60 years. 
 Sex: both gender 
 Patient having main symptoms of shoulder joint pain, radiating towards 
upper arm and forearm, numbness, restricted movement of upper limb, 
loss of abduction and forwarded flexion followed by stiffness of the 
shoulder joints.  
 Patient willing to sign the informed consent stating that he / she will 
consciously stick to the treatment during 30 days. But can opt out of the 
trial of his / her own. 
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 Willing for doing laboratory investigations and X-ray imaging. 
 Diabetes mellitus. 
 
Exclusion criteria: 
 
 Rheumatoid Arthritis. 
 Cervical spondylosis. 
 Ischemic heart diseases. 
 Systemic hypertension. 
 Pregnancy and lactation. 
 Recent shoulder dislocation. 
 
Duration of treatment: 
 
 Mukkirattai Chooranam was given 2gm b.i.d. with hot water for 30 days. 
Patients were followed under the guidance and supervision of the Head of the 
Department, Professor, Reader, Lecturer and Assistant Lecturer of Department of 
Pothu Maruthuvam, Government Siddha Medical College, Palayamkottai. 
 
 Totally 40 patients were selected and studied, the medical history, clinical 
examinations and every investigation, pain assessment score will be noted for each 
and every patient. 
 
Formation of clinical parameters: 
 
 History including, past, personal, family, dietary, occupation and seasonal 
variation. 
 
Lab Investigations: 
 
 Blood: TC, DC, ESR, HB, Blood sugar, Blood urea, Creatinine, Serum 
cholesterol, Uric acid, RA factor. 
 
Urine: 
 
 Albumin 
 Sugar 
 Deposit 
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Specific Investigation: 
 
 X-Ray of affected shoulder joint (AP and lateral view). 
 ECG for some selected cases (R/O Ischemic heart disease). 
 
Assessment of out come: 
 
 Pain assessment by oxford shoulder score. 
 
Investigation based on Siddha system: 
 
Envagai Thervugal: 
 
 Naadi, Sparisam, Naa, Niram, Mozhi, Vizhi, Malam, Moothiram. 
 
Neer kuri: 
 
 Niram, Manam, Eadai, Nurai, Enjal. 
 
Nei kuri: 
 
 A case sheet proforma is prepared on the basis of the Siddha Methodology i.e., 
Envagai Thervugal, Mukkutram, Nilam, Kaalam, Udal Thathugal. Individual case 
sheet is maintained for each patient. 
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CHAPTER-V 
RESULTS AND OBSERVATIONS 
 
 The randomized clinical trial Phase-II open labelled study was done among 20 
In patients and 20 Out patients were treated in Department of Pothu Maruthuvam, 
Government Siddha Medical College, Palayamkottai. The patients were treated with 
clinical trial medicine Mukkiratti Chooranam 2 gm twice a day with hot water for 
30 days. Result were observed with respect to following criteria. 
 
1. Sex Distribution 
2. Age Distribution 
3. Kaalam 
4. Thegi 
5. Gunam 
6. Religion 
7. Paruvakaalam 
8. Thinai 
9. Occupational status 
10. Diet 
11. Socio-Economical status 
12. Aetiological Factor 
13. Mode of Inset 
14. Duration of illness 
15. Clinical manifestation 
16. Grananendrium 
17. Kanmendrium 
18. Conditions of Mukkutram (Vatha, Pitha, Kapha) 
19. Udal Kattukal 
20. Envagai Thervugal 
21. Naadi 
22. Neer kuri 
23. Nei kuri 
24. Assessment of outcome 
24. Gradation of results 
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25. Laboratory Findings 
 a). Out patients 
 b). In patients 
26. Case summary 
 a). Out patients 
 b). In patients 
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1. SEX DISTRIBUTION: 
 
Table-1 Illustrates the Sex Distribution and its percentage. 
 
 
TABLE-1 
SEX DISTRIBUTION  
 
Sl. 
No. 
Sex 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. Male 10 50% 10 50% 
2. Female 10 50% 10 50% 
 Total 20 100% 20 100% 
 
 Among 20 Out patients, 50% were Male and 50% were Female. 
Among 20 In patients, 50% were Male and 50% were Female. 
 
FIGURE-1 
SEX DISTRIBUTION  
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2. AGE DISTRIBUTION: 
 
Table-3 Illustrates the Age Distribution and its percentage. 
 
TABLE-2 
AGE DISTRIBUTION 
 
Sl. 
No. 
Age groups  
(in Years) 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. 31 – 40 2 10% 1 5% 
2. 41 – 50 7 35% 5 25% 
3. 51 – 60 11 55% 14 70% 
 Total 20 100% 20 100% 
 
 Among 20 Out patients, 10% were in the age group of 31 – 40 years, 35% 
were in the age group of 41 – 50 years, 55% were in the age group of 51 – 60 years. 
Among 20 In patients, 5% were in the age group of 31 – 40 years, 25% were 
in the age group of 41 – 50 years, 70% were in the age group of 51 – 60 years. 
 
FIGURE-2 
AGE DISTRIBUTION 
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3. KAALAM: 
Table-3 Illustrates the Kaalam and its percentage. 
 
TABLE-3 
KAALAM 
Sl. 
No. 
Kaalam 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. Kapha Kaalam - - - - 
2. Pitha Kaalam 20 100% 20 100% 
3. Vatha Kaalam - - - - 
 Total 20 100% 20 100% 
 
In Siddha literature age of individual is fixed as 100 is to 3 Kaalam as, 
 Kapha kaalam - First 33 years and 4 months. 
 Pitha kaalam - Second 33 years and 4 months. 
 Vatha kaalam - Third 33 years and 4 months. 
 Among 20 Out patients and In patients, 100% of the cases belongs to Pitha 
Kaalam. 
FIGURE-3 
KAALAM 
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4. CONSTUTION OF THE BODY: 
 
Table-4 Illustrates the Constitution of The Body and its percentage. 
 
TABLE-4 
CONSTITUTION OF THE BODY 
 
Sl. 
No. 
Constitution of 
the body 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. Vatha Thegi - - - - 
2. Pitha Thegi - - - - 
3. Kapha Thegi - - - - 
4. Thontha Thegi 20 100% 20 100% 
 Total 20 100% 20 100% 
 
Among 20 Out patients, 100% were Thontha Thegi. 
Among 20 In patients, 100% were Thontha Thegi. 
FIGURE-4 
CONSTITUTION OF THE BODY 
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5. GUNAM: 
 
Table-5 Illustrates the Gunam and its percentage. 
 
 
TABLE-5 
GUNAM 
 
Sl. 
No. 
Gunam 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. Sathuva gunam - - - - 
2. Rajo gunam 20 100% 20 100% 
3. Thamasa gunam - - - - 
 Total 20 100% 20 100% 
 
 Among 20 Out patients, 100% had Rajo Gunam. 
 Among 20 In patients, 100% had Rajo Gunam. 
 
FIGURE-5 
GUNAM 
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6. RELIGION DISTRIBUTION: 
 
Table-6 Illustrates the Religion Distribution and its percentage. 
 
 
TABLE-6 
RELIGION DISTRIBTUTION 
 
Sl. 
No. 
Religion 
Distribution 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. Hindu 15 75% 20 100% 
2. Muslim 2 10% - - 
3. Christian 3 15% - - 
 Total 20 100% 20 100% 
 
Among 20 Out patients, 75% were Hindu, 10% were Muslim and 15% were 
Christian. 
Among 20 In patients, 100% were Hindu. 
 
FIGURE-6 
RELIGION DISTRIBTUTION 
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7. PARUVA KAALAM: 
 
Table-7 Illustrates the Paruva Kaalam and its percentage. 
 
TABLE-7 
PARUVA KAALAM 
 
Sl. 
No. 
Paruva Kaalam 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. Kaar kaalam - - - - 
2. Koothir kaalam - - - - 
3. Munpani kaalam 18 90% 2 10% 
4. Pinpani kaalam 2 10% 9 45% 
5. Elavenil kaalam - - 9 45% 
6. Mudhu venil kaalam - - - - 
 Total 20 100% 20 100% 
 
Among 20 Out patients, 90% cases were affected in Munpani kaalam, 10% 
cases were affected in Pinpani kaalam.  Among 20 IP patients, 10% cases were 
affected in Munpani kaalam, 45% cases were affected in Pinpani kaalam and 45% 
cases were affected in Elavenil kaalam. 
FIGURE-7 
PARUVA KAALAM 
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8. THINAI: 
 
Table-8 Illustrates the Thinai and its percentage., 
 
TABLE-8 
THINAI 
 
Sl. 
No. 
Thinai 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. Kurinji  - - - - 
2. Mullai - - - - 
3. Marutham 20 100% 18 90% 
4. Neithal  - - 2 10% 
5. Paalai - - - - 
 Total 20 100% 20 100% 
 
Among 20 Out patients, 100% cases were in Marutham. 
Among 20 In patients, 90% cases were in Marutham and 10% cases were in 
Neithal. 
FIGURE-8 
THINAI 
52 
 
0%
10%
20%
30%
40%
50%
60%
Labour
House wife
Clerk
Driver
35% 
20% 
15% 
30% 
55% 
35% 
5% 
5% 
P
e
rc
e
n
ta
ge
 
Occupation 
OP
IP
9. OCCUPATION: 
 
Table-9 Illustrates the Occupation and its percentage. 
 
TABLE-9 
OCCUPATION 
Sl. 
No. 
Occupation 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. Labour 7 35% 11 55% 
2. House wife 4 20% 7 35% 
3. Clerk 3 15% 1 5% 
4. Driver 6 30% 1 5% 
 Total 20 100% 20 100% 
 
Among 20 Out patients, 35% cases were Labours, 20% were House Wife, 
15% were Clerk and 30% were Driver. 
Among 20 In patients, 55% cases were Labours, 35% cases were House Wife, 
5% cases were Clerk and 5% cases were Driver. 
FIGURE-9 
OCCUPATION 
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10. FOOD HABITS: 
 
Table-10 Illustrates the Food Habits and its percentage. 
 
 
TABLE-10 
FOOD HABITS 
 
Sl. 
No. 
Food Habits 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. Vegetarian 2 10% 3 15% 
2. Non – Vegetarian 18 90% 17 85% 
 Total 20 100% 20 100% 
 
Among 20 Out patients, 10% cases were Vegetarian and 90% cases were Non 
– Vegetarian. 
Among 20 In patients, 15% cases were Vegetarian and 85% cases were Non – 
Vegetarian. 
FIGURE-10 
FOOD HABITS 
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11. SOCIO-ECONOMICAL STATUS: 
 
Table-11 Illustrates the Socio-Economical Status and its percentage. 
 
 
TABLE-11 
SOCIO – ECONOMICAL STATUS 
 
Sl. 
No. 
Socio-Economical 
Status 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. High income class - - - - 
2. Middle income class 6 30% 5 25% 
3. Low income class 14 70% 15 75% 
 Total 20 100% 20 100% 
 
Among 20 Out patients, 30% cases were Middle income class and 70% cases 
were Low income class. 
Among 20 In patients, 25% cases were Middle income class and 75% cases 
were Low income class. 
FIGURE-11 
SOCIO – ECONOMICAL STATUS 
0%
10%
20%
30%
40%
50%
60%
70%
80%
High income class
Middle income class
Low income class
0% 
30% 
70% 
0% 
25% 
75% 
P
e
rc
e
n
ta
ge
 
Socia - Economical Status 
OP
IP
55 
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
Age Occupation Miscellaneous
80% 
20% 
0% 
85% 
15% 
0% 
P
e
rc
e
n
ta
ge
 
Aetiological factors 
OP
IP
12. AETIOLOGICAL FACTORS: 
Table-12 Illustrates the Aetiological Factors and its percentage. 
 
TABLE-12 
AETOLOGICAL FACTORS 
 
Sl. 
No. 
Aetiological 
Factors 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. Age 16 80% 17 85% 
2. Occupation 4 20% 3 15% 
3. Miscellaneous - - - - 
 Total 20 100% 20 100% 
 
Among 20 Out patients, 80% of the cases were due to Age factor and 20% of 
the cases were due to Occupational. 
Among 20 In patients, 85% of the cases were due to Age factor and 15% of 
the cases were due to Occupational. 
FIGURE-12 
AETIOLOGICAL FACTORS 
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13. MODE OF ONSET: 
 
Table-13 Illustrates the Mode of Onset and its percentage. 
 
TABLE-13 
MODE OF ONSET 
 
Sl. 
No. 
Mode of Onset 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. Acute - - - - 
2. Chronic 20 100% 20 100% 
 Total 20 100% 20 100% 
 
 
Among 20 Out patients, 100% of the cases were Chronic onset. 
Among 20 In patients, 100% of the cases were Chronic onset. 
 
FIGURE-13 
MODE OF ONSET 
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14. DURATION OF ILLNESS: 
 
Table-14 Illustrates the Duration of Illness and its percentage. 
 
TABLE-14 
DURATION OF ILLNESS 
Sl. 
No. 
Duration of Illness 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. 1 – 2 months - - 3 15% 
2. 2 - 3 months 11 55% - - 
3. 3 – 4 months 4 20% 2 10% 
4. 4 – 5 months - - 3 15% 
5. 5 – 6 months - - 1 5% 
6. 6 – 7 months 5 25% 8 40% 
7. 7 – 8 months - - - - 
8. Above 8 months - - 3 15% 
 Total 20 100% 20 100% 
 
Among 20 Out patients, Duration of Illness is 55% in 2 – 3 months, 20% in 3 
– 4 months and 25% in 6 – 7 months. 
Among 20 In patients, Duration of Illness is 15% in 1-2 months, 10% in 3 – 4 
months, 15% in 4 – 5 months, 5 % in 5 – 6 months, 40% in 6 – 7 months and 15% in 
above 8 months. 
FIGURE-14 
DURATION OF ILLNESS 
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15. CLINICAL MANIFESTATION: 
 
Table-15 Illustrates the Clinical Manifestation and it percentage. 
 
TABLE-15 
CLINICAL MANIFESTATION 
Sl. 
No. 
Clinical manifestation 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. Painful shoulder 20 100% 20 100% 
2. Stiffness 16 80% 18 90% 
3. Tenderness 8 40% 11 55% 
4. Difficulty in moving 
the shoulder joint 
15 75% 10 50% 
 
Among 20 Out patients, 100% of the cases had Painful shoulder, 80% of the 
cases had Stiffness, 40% of the cases had Tenderness, and 75% of the cases had 
Difficulty in moving the shoulder joint. 
Among 20 In patients, 100% of the cases had Pain in their shoulder, 90% of 
the cases had Stiffness, 55% of the cases had Tenderness, and 50% of the cases had 
Difficulty in moving the shoulder joint. 
 
FIGURE-15 
CLINICAL MANIFESTATION 
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16. GNANENDRIUM: 
 
Table-16 Illustrates the Gnanendrium and its percentage. 
 
 
TABLE-16 
GNANENDRIUM 
 
Sl. 
No. 
Gnanendrium 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. Mei 20 100% 20 100 
2. Vai - - - - 
3. Kan - - - - 
4. Mookku - - - - 
5. Sevi - - - - 
 Total 20 100% 20 100% 
 
In both Out patients and In patients, 100% Mei was affected. 
FIGURE-16 
GNANENDRIUM 
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17. KANMENDRIUM: 
 
Table-17 Illustrates the Kanmendrium and its percentage.  
 
 
TABLE-17 
KANMENDRIUM 
 
Sl. 
No. 
Kanmendrium 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. Vaai - - - - 
2. Kaal - - - - 
3. Kai 20 100% 20 100% 
4. Eruvai - - - - 
5. Karuvai - - - - 
 Total 20 100% 20 100% 
 
In both Out patients and In patients, 100% Kai was affected. 
FIGURE-17 
KANMENDRIUM 
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18. CONDITIONS OF MUKKUTRAM: 
 
Table-18 (a). Illustrates the Condition in Vatham and its percentage. 
 
TABLE-18 (a) 
CONDITION IN VATHAM 
 
Sl. 
No. 
Condition in 
Vatham 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. Piranan 2 10% 2 10% 
2. Abanan - - - - 
3. Viyanan 20 100% 20 100% 
4. Udhanan - - - - 
5. Samanan 20 100% 20 100% 
6. Naagan - - - - 
7. Koorman - - - - 
8. Kirukaran - - - - 
9. Dhevathathan 2 10% 2 10% 
10. Dhananjeyan - - - - 
 
Among 20 Out patients, 10% of the cases were affected in Piranan, 
100% of the cases affected in Viyanan, 100% of the cases were affected in 
Samanan and 10% of the cases were affected in Dhevathathan. 
Among 20 In patients, 10% of the cases were affected in Piranan, 
100% of the cases affected in Viyanan, 100% of the cases were affected in 
Samanan and 10% of the cases were affected in Dhevathathan. 
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FIGURE-18 (a) 
CONDITION IN VATHAM 
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18 (b). CONDITIONS OF PITHAM: 
 
Table-18 (b) Illustrates the Condition in Pitham and its percentage. 
 
TABLE-18 (b) 
CONDITION IN PITHAM 
 
Sl. 
No. 
Condition in 
Pitham 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. Anala pitham - - - - 
2. Ranjagam - - - - 
3. Prasagam - - - - 
4. Alosagam - - - - 
5. Sathagam 20 100% 20 100% 
 
Among 20 Out patients, 100% of the cases were affected in Sathagam 
and Among 20 In Patients 100% of the cases were affected in Sathagam. 
 
FIGURE-18 (b) 
CONDITION IN PITHAM 
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18 (c). CONDITIONS IN KAPHAM: 
 
Table-18 (c) Illustrates the Condition in Kapham. 
 
TABLE-18 (c) 
CONDITION IN KAPHAM 
 
Sl. 
No. 
Condition in 
Kapham 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. Avalambagam - - - - 
2. Kilethagam - - - - 
3. Pothagam - - - - 
4. Tharpagam - - - - 
5. Santhigam 20 100% 20 100% 
 
Among 20 Out patients, 100% of the cases were affected in Santhigam 
and Among 20 In Patients 100% of the cases were affected in Santhigam. 
FIGURE-18 (c) 
CONDITION IN KAPHAM 
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19. INVOLVEMENT OF UDAL THATHUKKAL: 
 
Table-19 Illustrates the involvement of Udal thathukkal and its percentage. 
 
TABLE-19 
INVOLVEMENT OF UDAL THATHUKKAL 
 
Sl. 
No. 
Udal Thathukkal 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. Saaram 20 100% 20 100% 
2. Senneer - - - - 
3. Oon - - - - 
4. Kozhuppu 10 50% 10 50% 
5. Enbu 20 100% 20 100% 
6. Moolai - - - - 
7. Sukkilam / 
suronitham 
- - - - 
 
Among 20 Out patients, 100% of the cases were affected in Saaram, 
50% of the cases were affected in Kozhuppu and 100% of the cases were 
affected in Enbu. 
Among 20 In patients, 100% of the cases were affected in Saaram, 
50% of the cases were affected in Kozhuppu and 100% of the cases were 
affected in Enbu. 
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FIGURE-19 
INVOLVEMENT OF UDAL THATHUKKAL 
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20. CONDITIONS OF ENVAGAI THERVUGAL: 
 
Table-20 Illustrates the conditions of Envagai Thervugal and its percentage. 
 
TABLE-20 
CONDITIONS OF ENVAGAI THERVUGAL 
 
Sl. 
No. 
Envagai Thervugal 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. Naa - - - - 
2. Niram - - - - 
3. Mozhi - - - - 
4. Vizhi - - - - 
5. Malam - - - - 
6. Moothiram - - - - 
7. Sparisam 15 75% 10 50% 
8. Naadi (Thontha 
Naadi) 
20 100% 20 100% 
 
Among 20 Out patients, 75% of the cases were affected in Sparisam, 
and 100% of the cases had Thontha Naadi. 
Among 20 In patients, 75% of the cases were affected in Sparisam, and 
100% of the cases had Thontha Naadi. 
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FIGURE-20 
CONDITIONS OF ENVAGAI THERVUGAL 
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21. NAADI: 
 
Table-21 Illustrates the Naadi and its percentage. 
 
TABLE-21 
NAADI 
Sl. 
No. 
Naadi 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. Vatha Pitham 16 80% 20 100% 
2. Vatha Kapham - - - - 
3. Pitha Vatham 4 20% - - 
4. Pitha Kapham - - - - 
5. Kapha Vatham - - - - 
6. Kapha Pitham - - - - 
 Total 20 100% 20 100% 
 
Among 20 Out patients, 80% of the cases were Vatha Pitham and 20% of the 
cases were Pitha Vatham. Among 20 In patients, 100% of the cases were Vatha 
Pitham. 
FIGURE-21 
NAADI 
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22. NEER KURI 
 
Table-22 Illustrates the Neer Kuri and its percentage. 
 
TABLE-22 
NEER KURI 
 
Sl. 
No. 
Neer kuri 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. Niram 6 30% 7 35% 
2. Manam - - - - 
3. Edai - - - - 
4. Nurai 4 20% 2 10% 
5. Enjal  - - - - 
 
Among 20 Out patients 30% of the cases were affected in Niram and 20% 
cases of the cases were affected in Nurai. Among 20 In patients 35% of the cases 
were affected in Niram and 10% of the cases were affected in Nurai. 
FIGURE-22 
NEER KURI 
  
71 
 
0%
20%
40%
60%
80%
100%
Vatha Neer
(Spreading like
snake)
Pitha Neer
Spreading like
ring)
Kapha Neer
(Spreading
pearl)
Thontha Neer
(Asathiya Nei
Kurigal)
100% 
0% 
0% 
0% 
100% 
0% 
0% 
0% 
P
e
rc
e
n
ta
ge
 
Nei Kuri 
OP
IP
23. NEI KURI 
 
Table-22 Illustrates the Neikuri and its percentage. 
 
TABLE-23 
NEI KURI 
 
Sl. 
No. 
Nei kuri 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. Vatha Neer  
(Spreading like snake) 
20 100% 20 100% 
2. Pitha Neer Spreading 
like ring) 
- - - - 
3. Kapha Neer 
(Spreading pearl) 
- - - - 
4. Thontha Neer 
(Asathiya Nei Kurigal) 
- - - - 
 Total 20 100% 20 100% 
 
Among 20 Out patients and 20 In patients 100% of the cases were vatham. 
 
FIGURE-23 
NEI KURI 
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24. ASSESSMENT OF OUTCOME; 
 
 Table-24 Illustrates the pain assessment scale and its percentage. 
 
TABLE-24 
ASSESSMENT OF OUTCOME  
Sl. 
No. 
Pain 
scale 
Before Treatment After Treatment 
Out 
Patients 
(OP) 
In Patients 
(IP) 
Out 
Patients 
(OP) 
In 
Patients 
(IP) 
N
o.
 o
f 
C
as
es
 
P
er
ce
nt
ag
e 
(%
) 
N
o.
 o
f 
C
as
es
 
P
er
ce
nt
ag
e 
(%
) 
N
o.
 o
f 
C
as
es
 
P
er
ce
nt
ag
e 
(%
) 
N
o.
 o
f 
C
as
es
 
P
er
ce
nt
ag
e 
(%
) 
1. 0 – 19 12 60% 2 10% 11 55% 2 10% 
2. 20 – 29 5 25% 3 15% 5 25% 2 10% 
3. 30 – 39 3 15% 2 10% 4 20% 2 10% 
4. 40 – 48 0 0% 13 65% 0 0 0 0% 
  
Assessment of out come: 
Oxford shoulder score: 
 0-19  indicate severe shoulder arthritis 
 20-29  indicate moderate to severe 
 30-39  indicate middle to moderate 
 40-48  indicate satisfactory joint function 
 Ref: F. Younis, J.Sultan, S.Dire, P.J. Hughes the range of the oxford shoulder 
score in the asymptomatic population , Vol.8, Page No.93, Edition Nov.2011. 
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 Before Treatment: 
Pain score OP IP 
0-19 60% 55% 
20-29 25% 25% 
30-39 15% 20% 
40-48 0% 0% 
 
 High incidence of outcome is reported in the pain score range between 0-19. 
 
 After Treatment: 
 
Pain score OP IP 
0-19 10% 10% 
20-29 15% 10% 
30-39 10% 10% 
40-48 65% 70% 
 
 High incidence of outcome is reported in the pain score range between 40-48. 
 
FIGURE-24 
ASSESSMENT OF OUTCOME  
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25. GRADATION OF RESULTS: 
 
 Table-25 Illustrates the pain Gradation Results and its percentage. 
 
TABLE-25 
GRADATION OF RESULTS 
  
Sl. 
No. 
Results 
Out Patients (OP) In Patients (IP) 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
1. Improve 13 65% 14 70% 
2. Moderately 
improved 
4 20% 4 20% 
3. Not improved 3 15% 2 10% 
 Total 20 100% 20 100% 
 
 
  Among In patients, 65% of cases were Improved, 20% of cases were 
Moderately improved and 15% of cases were Not improved. 
 Among Out patients, 70% of cases were Improved, 20% of cases were 
Moderately improved and 10% of cases were Not improved. 
 
FIGURE-25 
GRADATION OF RESULTS 
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TABLE-26 LABORATORY INVESTIGATION   
a). Out Patients  
Sl
. N
o.
 
O
ut
 P
at
ie
nt
 N
o.
 
HAEMOTOLOGICAL REPORT BIO-CHEMICAL ANALYSIS URINE ANALYSIS 
BEFORE TREATMENT AFTER TREATMENT 
BEFORE 
TREATMENT 
AFTER  
TREATMENT 
BEFORE 
TREATMENT 
AFTER  
TREATMENT 
TC 
DC 
ESR 
(mm) 
Hb% 
(gms) 
TC 
DC 
ESR 
(mm) 
Hb% 
(gms) Su
ga
r 
U
re
a 
C
ho
le
st
er
ol
  
Su
ga
r 
U
re
a 
C
ho
le
st
er
ol
  
A
lb
um
in
 
Su
ga
r 
D
ep
- 
E
pi
. c
el
ls
 / 
P
us
 c
el
ls
 
A
lb
um
in
 
Su
ga
r 
D
ep
- 
E
pi
 c
el
ls
 / 
P
us
 c
el
ls
 
P
 
L
 
E
 
½
 H
r.
 
1 
H
r.
 
P
 
L
 
E
 
½
 H
r.
 
1 
H
r.
 
1.  8729 8600 64 34 5 10 12 11.40 8400 62 36 4 8 10 11.40 212 17 144 210 19 146 NIL NIL NAD NIL NIL NAD 
2.  9171 8300 61 37 3 14 18 10.40 8200 63 34 3 7 18 10.40 173 14 149 170 12 146 NIL NIL NAD NIL NIL NAD 
3.  9236 8400 63 35 2 12 20 12.60 8300 60 32 2 12 12 12.60 179 20 188 176 18 182 NIL NIL NAD NIL NIL NAD 
4.  9998 8800 66 30 4 10 16 11.80 8600 68 36 4 10 18 11.80 192 18 183 190 16 180 NIL NIL NAD NIL NIL NAD 
5.  10048 8600 70 26 4 12 16 10.80 8800 72 24 4 14 12 10.80 182 16 167 180 18 164 NIL Trace 1-2 pus 
cells 
NIL NIL NAD 
6.  10970 8500 68 28 5 15 20 12.20 8600 66 30 5 6 18 12.20 180 22 130 176 20 128 NIL NIL NAD NIL NIL NAD 
7.  11199 7800 60 36 4 10 14 11.60 7600 64 34 4 14 13 11.60 112 13 168 116 14 162 NIL NIL NAD NIL NIL NAD 
8.  11248 7600 64 32 3 16 10 12.80 7800 66 36 3 10 18 12.80 234 15 154 230 16 152 NIL NIL NAD NIL NIL NAD 
9.  11248 8200 56 38 2 9 18 11.20 8400 58 32 2 15 14 11.20 232 17 180 228 15 176 NIL NIL NAD NIL NIL NAD 
10.  11353 8600 58 40 2 16 20 12.40 8800 56 44 2 7 18 12.40 225 19 182 221 18 180 NIL NIL NAD NIL NIL NAD 
11.  13655 7500 64 32 6 10 18 12.60 7300 66 28 6 11 6 12.60 144 21 160 142 20 158 NIL NIL Few pus 
cells 
NIL NIL NAD 
12.  14130 7200 66 32 4 8 10 12.80 7400 68 34 4 3 8 12.80 282 23 205 280 22 200 NIL NIL NAD NIL NIL NAD 
13.  14357 7400 70 28 3 14 18 11.80 7200 64 32 3 4 16 11.80 230 18 174 228 19 172 NIL NIL NAD NIL NIL NAD 
14.  14763 8000 68 30 2 10 16 11.20 8200 65 34 2 13 18 11.20 216 17 182 214 18 180 NIL NIL NAD NIL NIL NAD 
15.  14837 8200 66 36 3 16 20 11.80 8400 68 34 3 12 18 11.80 228 20 186 224 19 184 NIL NIL NAD NIL NIL NAD 
16.  15316 8400 64 32 4 12 14 12.80 8300 62 30 4 9 20 12.80 214 19 172 212 20 170 NIL NIL NAD NIL NIL NAD 
17.  15387 8700 68 26 5 9 16 10.80 8600 70 28 5 10 16 10.80 220 22 166 218 21 164 NIL NIL NAD NIL NIL NAD 
18.  15388 8500 64 30 6 13 20 11.60 8400 66 32 6 8 20 11.60 230 24 184 228 23 180 NIL NIL NAD NIL NIL NAD 
19.  15700 8200 60 34 4 7 14 12.80 8300 64 30 4 11 12 12.80 216 15 168 214 16 170 NIL NIL NAD NIL NIL NAD 
20.  17605 8800 56 38 2 13 20 11.00 8600 58 36 2 6 16 11.00 222 23 178 220 21 174 NIL NIL NAD NIL NIL NAD 
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TABLE-26 LABORATORY INVESTIGATION   
b). In Patients  
 S
l. 
N
o.
 
In
 P
at
ie
nt
 N
o.
 
HAEMOTOLOGICAL REPORT BIO-CHEMICAL ANALYSIS URINE ANALYSIS 
BEFORE TREATMENT AFTER TREATMENT 
BEFORE 
TREATMENT 
AFTER  
TREATMENT 
BEFORE 
TREATMENT 
AFTER  
TREATMENT 
TC 
DC 
ESR 
(mm) 
Hb% 
(gms) 
TC 
DC 
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(mm) 
Hb% 
(gms) Su
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ls
 
P
 
L
 
E
 
½
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r.
 
1 
H
r.
 
P
 
L
 
E
 
½
 H
r.
 
1 
H
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1.  218 8200 62 34 4 16 18 10.60 8000 64 34 6 10 14 10.80 358 17 192 354 15 190 NIL NIL NAD NIL NIL NAD 
2.  388 7000 58 40 2 14 16 11.20 7200 58 38 4 8 16 11.20 145 27 149 142 24 146 NIL NIL NAD NIL NIL NAD 
3.  420 8400 60 38 2 18 30 9.40 9400 58 38 4 10 10 9.90 177 29 262 174 25 260 NIL NIL NAD NIL NIL NAD 
4.  483 8400 60 36 4 12 14 11.00 8600 62 36 4 8 12 11.40 105 40 196 108 38 194 NIL NIL 1-2 pus 
cells 
NIL NIL NAD 
5.  535 8300 60 37 3 14 18 10.20 8400 58 38 4 10 12 10.60 367 26 165 364 24 162 NIL +++ 1-2 pus 
cells 
NIL NIL NAD 
6.  783 8600 64 33 3 13 18 10.40 8800 60 36 4 6 8 10.60 285 22 163 282 20 160 NIL NIL NAD NIL NIL NAD 
7.  859 7800 55 40 5 14 18 11.90 7600 55 40 5 8 10 12.20 318 27 140 314 25 138 NIL +++ Few pus 
cells 
NIL NIL NAD 
8.  881 7600 56 38 6 15 20 10.40 7400 57 32 6 8 12 10.60 220 22 152 216 20 150 NIL NIL NAD NIL NIL NAD 
9.  897 7200 62 34 4 14 18 11.20 7000 60 36 4 7 10 11.60 232 21 156 230 18 154 NIL NIL NAD NIL NIL NAD 
10.  910 8800 60 38 2 18 20 11.80 8600 60 38 2 6 8 12.20 210 18 160 208 16 156 NIL NIL NAD NIL NIL NAD 
11.  969 7400 62 34 4 17 20 10.80 7500 60 38 4 10 12 11.00 228 22 172 224 20 170 NIL NIL NAD NIL NIL NAD 
12.  1100 7200 63 32 5 16 18 11.40 7400 62 32 6 8 10 11.60 205 20 158 203 18 160 NIL NIL NAD NIL NIL NAD 
13.  1116 8600 60 36 4 13 16 10.40 8400 60 36 4 10 12 10.60 216 18 160 214 16 162 NIL NIL NAD NIL NIL NAD 
14.  1127 8800 62 35 3 15 19 10.60 8600 60 35 5 7 9 10.80 225 17 164 223 15 163 NIL NIL NAD NIL NIL NAD 
15.  1140 8600 63 35 2 16 15 11.20 8800 62 34 4 10 12 11.40 230 15 162 228 13 160 NIL NIL NAD NIL NIL NAD 
16.  1149 8400 60 37 2 14 16 11.40 8200 60 42 2 10 12 11.60 218 18 168 216 16 166 NIL NIL NAD NIL NIL NAD 
17.  1160 8200 63 34 3 18 20 12.20 8400 63 34 3 11 13 12.40 180 21 170 178 20 168 NIL NIL NAD NIL NIL NAD 
18.  1180 8600 58 38 4 13 16 12.40 8800 58 36 6 6 8 12.60 172 25 172 170 23 170 NIL NIL NAD NIL NIL NAD 
19.  1221 8300 54 40 3 16 20 10.80 8600 58 30 2 10 12 11.00 186 24 174 184 22 172 NIL NIL NAD NIL NIL NAD 
20.  1231 8600 54 40 6 16 18 10.80 8400 54 40 6 8 10 11.00 157 19 117 153 17 115 NIL NIL NAD NIL NIL NAD 
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TABLE-27 CASE SUMMARY  
(a) OUT PATIENTS 
Sl. 
No. 
OP 
No. 
Name 
Age / 
Sex 
Treatment 
starting date 
End of the 
treatment 
date 
Duration 
of Illness 
Treatment 
with Dose 
Total 
No. of 
days 
treated 
Radiological findings Result 
1. 8729 Indira 48 / F 27.01.2016 25.02.2016 4 Months 
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30 Normal Good 
2. 9171 Boominathan 60 / M 28.01.2016 26.02.2016 6 Months 30 Osteophytic change + Fair 
3. 9236 Ramanujam 60 / M 28.01.2016 26.02.2016 4 Months 30 Narrowing of joint space Fair 
4. 9998 Valliammal 52 / F 30.01.2016 28.02.2016 3 Months 30 Normal Good 
5. 10048 Mari 35 / F 30.01.2016 28.02.2016 4 Months 30 Narrowing of joint space Fair 
6. 10910 Madasamy 60 / M 02.02.2016 02.03.2016 6 Months 30 Osteophytic change + Fair 
7. 11199 Sankarammal 55 / F 03.02.2016 03.03.2016 6 Months 30 Normal Good 
8. 11248 Mohammed Raja 42 / M 03.02.2016 03.03.2016 3 Months 30 Normal Good 
9. 11285 Kannan 42 / M 03.02.2016 03.03.2016 3 Months 30 Osteophytic change + Fair 
10. 11353 Sumathi 45 / F 03.02.2016 03.03.2016 7 Months 30 Normal Good 
11. 13655 Srinivasan 57 / M 10.02.2016 10.03.2016 4 Months 30 Normal Good 
12. 14130 Ponpandi 58 / M 11.02.2016 11.03.2016 6 Months 30 Normal Good 
13. 14357 Saradha 58 / F 12.02.2016 12.03.2016 3 Months 30 Normal Good 
14. 14763 Murugan 60 / M 13.02.2016 13.03.2016 3 Months 30 Normal Good 
15. 14837 Sri Ram 40 / M 13.02.2016 13.03.2016 2 Months 30 Normal Good 
16. 15316 Jeyamary 60 / F 15.02.2016 15.03.2016 2 Months 30 Normal Good 
17. 15387 Mala Antony 47 / F 15.02.2016 15.03.2016 2 Months  30 Normal Good 
18. 15388 Akila Nepolien 43 / F 15.02.2016 15.03.2016 3 Months 30 Normal Good 
19. 15700 Thangamani 60 / F 16.02.2016 16.03.2016 2 Months 30 Osteophytic change + Fair 
20. 17605 Abdul Kadhar 43 / M 22.02.2016 24.03.2016 3 Months 30 Normal Good 
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TABLE-27 CASE SUMMARY  
 OUT PATIENTS 
Sl. 
No. 
OP No. Name 
Age / 
Sex 
RA 
Factors 
(IU / ml) 
ECG 
1. 8729 Indira 48 / F 16.5 Normal 
2. 9171 Boominathan 60 / M 12.2 Normal 
3. 9236 Ramanujam 60 / M 17.3 Normal 
4. 9998 Valliammal 52 / F 11.6 Normal 
5. 10048 Mari 35 / F 10.1 Normal 
6. 10910 Madasamy 60 / M 12.2 Normal 
7. 11199 Sankarammal 55 / F 13.1 Normal 
8. 11248 Mohammed Raja 42 / M 14.6 Normal 
9. 11285 Kannan 42 / M 11.8 Normal 
10. 11353 Sumathi 45 / F 18.2 Normal 
11. 13655 Srinivasan 57 / M 13.8 Normal 
12. 14130 Ponpandi 58 / M 12.8 Normal 
13. 14357 Saradha 58 / F 16.4 Normal 
14. 14763 Murugan 60 / M 17.5 Normal 
15. 14837 Sri Ram 40 / M 17.8 Normal 
16. 15316 Jeyamary 60 / F 12.3 Normal 
17. 15387 Mala Antony 47 / F 14.2 Normal 
18. 15388 Akila Nepolien 43 / F 16.2 Normal 
19. 15700 Thangamani 60 / F 18.7 Normal 
20. 17605 Abdul Kadhar 43 / M 19.2 Normal 
 
 Reference range: 
 
  Rheumatoid factor : Upto 20 IU/mL 
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TABLE-27 CASE SUMMARY  
(b) IN PATIENTS 
Sl. 
No. 
IP 
No. 
Name 
Age / 
Sex 
Treatment 
starting date 
End of the 
treatment 
date 
Duration 
of Illness 
Treatment 
with Dose 
No. of days 
treated 
Total 
No. of 
days 
treated 
Radiological findings 
R
es
ul
t 
IP Follow 
1. 218 Mani 60 / M 29.01.2016 27.02.2016 1 Month 
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30 - 30 Normal Good 
2. 288 Parvathi 60 / F 15.02.2016 16.03.2016 1 Year 31 - 31 Osteophytic changes + Fair 
3. 420 Sundari 50 / F 17.02.2016 18.03.2016 2 Months 31 - 31 Normal Good 
4. 483 Aavudaiyammal 49 / F 23.02.2016 04.03.2016 6 Months 11 19 30 Normal Good 
5. 535 Manikandan 59 / M 28.02.2016 28.03.2016 4 Months 30 - 30 Normal Good 
6. 783 Krishnamoorthy 60 / M 24.03.2016 23.04.2016 3 Months 31 - 31 Narrowing of joint space Fair 
7. 859 Mani 60 / M 29.03.2016 27.04.2016 6 Months 30 - 30 Normal Good 
8. 881 Velammal 60 / F 31.03.2016 22.04.2016 3 Months 23 7 30 Osteophytic changes + Fair 
9. 897 Subbammal 58 / F 02.04.2016 02.05.2016 6 Months 31 - 31 Normal Good 
10. 910 Mookammal 50 / F 03.04.2016 25.04.2016 5 Months 23 7 30 Normal Good 
11. 969 Latha 45 / F 08.04..2016 14.04.2016 7 Months 7 23 30 Normal Good 
12. 1100 Moorthi 60 / M 24.04.2016 23.05.2016 4 Months 30 - 30 Narrowing of joint space Fair 
13. 1116 Paramashivam 58 / M 26.04.2016 11.05.2016 1 Month 16 14 30 Normal Good 
14. 1127 Aarumugam 39 / F 27.04.2016 27.05.2016 6 Months 31 - 31 Normal Good 
15. 1140 Chettah 55 / M 28.04.2016 21.05.2016 8 Months 24 6 30 Normal Good 
16. 1149 Gomathi 50 / F 29.04.2016 21.05.2016 6 Months 23 7 30 Normal Good 
17. 1160 Parvathy 55 / F 02.05.2016 14.05.2016 4 Months  13 17 30 Normal Good 
18. 1180 Palpandi 56 / M 03.05.2016 01.06.2016 7 Months 30 - 30 Normal Good 
19. 1221 Ravindran 52 / M 07.05.2016 05.06.2016 7 Months 30 - 30 Normal Good 
20. 1231 Ramasamy 60 / M 09.05.2016 09.06.2016 1 Year 32 - 32 Osteophytic changes + Fair 
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TABLE-27 CASE SUMMARY  
 IN PATIENTS 
 
Sl. 
No. 
IP 
No. 
Name 
Age / 
Sex 
RA 
Factors 
(IU / ml) 
ECG 
1. 218 Mani 60 / M 16.4 Normal 
2. 288 Parvathi 60 / F 17.5 Normal 
3. 420 Sundari 50 / F 17.8 Normal 
4. 483 Aavudaiyammal 49 / F 13.8 Normal 
5. 535 Manikandan 59 / M 11.8 Normal 
6. 783 Krishnamoorthy 60 / M 14.2 Normal 
7. 859 Mani 60 / M 17.2 Normal 
8. 881 Velammal 60 / F 13.1 Normal 
9. 897 Subbammal 58 / F 10.8 Normal 
10. 910 Mookammal 50 / F 11.2 Normal 
11. 969 Latha 45 / F 18.6 Normal 
12. 1100 Moorthi 60 / M 9.6 Normal 
13. 1116 Paramashivam 58 / M 8.2 Normal 
14. 1127 Aarumugam 39 / F 17.2 Normal 
15. 1140 Chettah 55 / M 9.6 Normal 
16. 1149 Gomathi 50 / F 18.2 Normal 
17. 1160 Parvathy 55 / F 8.1 Normal 
18. 1180 Palpandi 56 / M 12.4 Normal 
19. 1221 Ravindran 52 / M 12.2 Normal 
20. 1231 Ramasamy 60 / M 14.3 Normal 
 
 Reference range: 
 
  Rheumatoid factor : Upto 20 IU/mL 
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CHAPTER-VI  
 
DISCUSSION 
 
 
 Among 80 types of Vatha disease, Kumba Vatham is one of them, 
characterized by inflammation of joint, stiffness and paining shoulder joint. 
 As the joint becomes progressively painful and stiffer, simple movement such 
as raising the arm becomes difficult. The inflammation occurs within the 
capsule itself. 
 So Vatha disease has received more attention and good prognosis is the field 
of alternative medicine, specially in Siddha medicine. But they need scientific 
approach to study and prove it. 
 All patients were subjected to preliminary investigations which include 
radiological, haematological and urine examination. 
 The trial medicine ‘Mukkirattai Chooranam’ was administered from the 
next day on wards. The course of treatment is 30 days twice a day with hot 
water. 
 20 Out and In patients were subjected on this, results can be discussed as 
follows, 
 
1. Sex Distribution: 
 
  Among 20 Out patients, 50% were Male and 50% were Female. 
 Among 20 In patients, 50% were Male and 50% were Female. 
 
2. Age Distribution: 
 
 Among 20 Out patients, 10% were in the age group of 31 – 40 
years, 35% were in the age group of 41 – 50 years, 55% were in the 
age group of 51 – 60 years. 
 Among 20 In patients, 5% were in the age group of 31 – 40 
years, 25% were in the age group of 41 – 50 years, 70% were in the 
age group of 51 – 60 years. 
 
3. Kaalam: 
 
 In Siddha literature age of individual is fixed as 100 is to 3 Kaalam as, 
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 Kapha kaalam - First 33 years and 4 months. 
 Pitha kaalam - Second 33 years and 4 months. 
 Vadha kaalam - Third 33 years and 4 months. 
 
  Among 20 Out patients and In patients, 100% of the cases belongs to 
 Pitha Kaalam. 
 
4. Constitution of the body: 
 
 Among 20 Out patients, 100% were Thontha Thegi. 
 Among 20 In patients, 100% were Thontha Thegi. 
 
5. Gunam: 
 
 Among 20 Out patients, 100% had Rajo Gunam. 
 Among 20 In patients, 100% had Rajo Gunam. 
 
6. Religion Distribution: 
 
Among 20 Out patients, 75% were Hindu, 10% were Muslim and 
15% were Christian. 
 Among 20 In patients, 100% were Hindu. 
 
7. Paruva Kaalam: 
 
Most of cases were affected in Munpani Kaalam, Pinpani Kaalam and 
Elavenil Kaalam. 
 
8. Thinai: 
 
  Among 20 Out patients, 100% cases were in Marutham. 
Among 20 In patients, 90% cases were in Marutham and 10% cases 
were in Neithal. 
 
9. Occupation: 
 
Among 20 Out patients, 35% cases were Labours, 20% were House 
Wife, 15% were Clerk and 30% were Driver. 
Among 20 In patients, 55% cases were Labours, 35% cases were 
House Wife, 5% cases were Clerk and 5% cases were Driver. 
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10. Food Habits: 
 
Among 20 Out patients, 10% cases were Vegetarian and 90% cases 
were Non – Vegetarian. 
Among 20 In patients, 15% cases were Vegetarian and 85% cases were 
Non – Vegetarian. 
 
11. Socio – Economical status: 
 
 Among 20 Out patients, 30% cases were Middle income class and 70% 
cases were Low income class. 
 Among 20 In patients, 25% cases were Middle income class and 75% 
cases were Low income class. 
 
12. Aetiological Factors: 
 
Among 20 Out patients, 80% of the cases were due to Age factor and 
20% of the cases were due to Occupational. 
Among 20 In patients, 85% of the cases were due to Age factor and 
15% of the cases were due to Occupational. 
 
13. Mode of onset: 
 
 Among 20 Out patients, 100% of the cases were Chronic onset. 
 Among 20 In patients, 100% of the cases were Chronic onset. 
 
14. Duration of illness: 
 
Among 20 Out patients, Duration of Illness is 55% in 2 – 3 months, 
20% in 3 – 4 months and Duration of Illness 25% in 6 – 7 months. 
Among 20 In patients, Duration of Illness is 15% in 1-2 months, 10% 
in 3 – 4 months, 15% in 4 – 5 months, 5 % in 5 – 6 months, 40% in 6 – 7 
months and 15% in above 8 months. 
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15. Clinical manifestation: 
 
Among 20 Out patients, 100% of the cases had Painful shoulder, 80% 
of the cases had Stiffness, 40% of the cases had Tenderness, and 75% of 
the cases had difficulty in moving the shoulder joint.  
Among 20 In patients, 100% of the cases had Painful shoulder, 90% of 
the cases had Stiffness, 55% of the cases had Tenderness, and 50% of the 
cases had difficulty in moving the shoulder joint. 
 
16. Gnanendrium: 
 
In both Out patients and In patients, 100% Mei was affected. 
 
17. Kanmendrium: 
 
 In both Out patients and In patients, 100% Kai was affected. 
 
18. Conditions of Mukkutram:  
 
18 (a). Condition of Vatham: 
 
Among 20 Out patients, 10% of the cases were affected in Piranan, 
100% of the cases affected in Viyanan, 100% of the cases were affected in 
Samanan and 10% of the cases were affected in Dhevathathan. 
Among 20 In patients, 10% of the cases were affected in Piranan, 
100% of the cases affected in Viyanan, 100% of the cases were affected in 
Samanan and 10% of the cases were affected in Dhevathathan. 
 
18 (b). Condition of Pitahm: 
 
Among 20 Out patients, 100% of the cases were affected in sathagam 
and Among 20 In Patients, 100% of the cases were affected in sathagam. 
 
18 (c). Condition of Kapham: 
 
Among 20 Out patients, 100% of the cases were affected in santhigam 
and Among 20 In Patients, 100% of the cases were affected in santhigam. 
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19. Involvement of Udal Thathukkal: 
 
Among 20 Out patients, 100% of the cases were affected in Saaram, 
50% of the cases were affected in Kozhuppu and 100% of the cases were 
affected in Enbu. 
Among 20 In patients, 100% of the cases were affected in Saaram, 
50% of the cases were affected in Kozhuppu and 100% of the cases were 
affected in Enbu. 
 
20. Conditions of Envagai Thervugal: 
 
Among 20 Out patients, 75% of the cases were affected sparisam, and 
100% of the cases had thontha naadi. 
Among 20 In patients, 75% of the cases were affected sparisam, and 
100% of the cases had thontha naadi. 
 
21. Naadi: 
 
Among 20 Out patients, 80% of the cases were Vatha Pitham and 20% 
of the cases were Pitha Vatham. 
Among 20 In patients, 100% of the cases were Vatha Pitham. 
 
22. Neer kuri: 
 
 Among 20 Out patients, 30% of the cases were affected in Niram and 
20% cases of the cases were affected in Nurai.  
 Among 20 In patients, 35% of the cases were affected in Niram and 
10% of the cases were affected in Nurai. 
 
23. Nei kuri:  
 
Among 20 Out patients and 20 In patients, 100% of the cases were 
vatham. 
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24. Assessment of outcome: 
 
  Before Treatment: 
Pain score OP IP 
0-19 60% 55% 
20-29 25% 25% 
30-39 15% 20% 
40-48 0% 0% 
 
 High incidence of outcome is reported in the pain score range 
between 0-19. 
 
  After Treatment: 
 
Pain score OP IP 
0-19 10% 10% 
20-29 15% 10% 
30-39 10% 10% 
40-48 65% 70% 
 
 
High incidence of outcome is reported in the pain score range between 
40-48. 
 
Trial medicine: 
 
 All the 40 patients treated with the clinical trial medicine Mukkirattai 
Chooranam with hot water for 30 days the disease and treatment are based primarily 
on the derangement of Mukkutram, which again is based on the Pancha Bootham 
theory.  Incidence of Kumbavatham and treatment are also based on these primary 
principles of Siddha medicine.  
 
 The bootham araises vatha kuttram in the body and so leads to degenerate and 
weakness of shoulder joints.  Increased vatha kutram is brought to normal mainly by 
kaippu suvai and thuvarppu suvai. 
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a) Space + Air = Kaippu 
b) Earth + Air = Thuvarppu 
 
Thus, they decreases the vatha kutram.  So, I conclude the trial drugs control 
the disease Kumbavatham and it comes under Ethirurai Maruthuvam. 
 
25. Gradation of results: 
 
Among In patients, 65% of cases were Improved, 20% of cases were 
Moderately improved and 15% of cases were Not improved. 
 Among Out patients, 70% of cases were Improved, 20% of cases were 
Moderately improved and 10% of cases were Not improved. 
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CHAPTER-VII 
 
SUMMARY 
 
 The purpose of the study is to reduce the symptoms of Kumba Vatham 
(Periarthritis). This premilinary study of anti-vatha along with rejuventation therapy 
has been tried with trial drugs and regiments. 
 
 The clinical trial drug MUKKIRATTI CHOORANAM is given prepared as 
per Siddha literature.  The duration of period is 30 days. 
 
 The clinical trial dose is MUKKIRATTAI CHOORANAM 2gms twice a 
day with hot water. 
 
 Total 40 patients of both sex 30 - 60 years with age group were selected based 
on inclusion and exclusion criteria. 
 
 Maximum incidence in age 30-60 years. Before treatment, routine blood and 
urine analysis were taken in all patients. 
 
 Siddha diagnostic methods like Udal thathukkal, Envagai Thervugal, Neer 
kuri and Nei kuri were documented. 
 
 The entire details of the patients were noted in the case sheet proforma. 
 
FROM THE CLINICAL STUDY THE FOLLOWING DATA WERE 
OBSERVED: 
 
 Age:  
 
 Most of the patients were affected in age of 30-60 years. 
 
 Sex: 
 
 Commonly affected in both sex. 
 
 Occupation: 
 
 Mostly affected in Labours, House wife and Drivers 
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 Mukkutram: 
 
 Vatham – Piranan, Samanan, Dheva thathan was affected. 
 Pitham – Sathagam was affected. 
 Kapham – Santhigam was affected. 
 
 Udal thathukkal: 
  
 Saaram,  Kozhuppu, Enbu was affected. 
 
 Naadi: 
  
 Vathapitha Naadi was commonly affected. 
 
 Neer kuri:  
 
 In most of the patients Vatham was affected. 
 
 
RESULTS AFTER TREATMENT: 
 
 65% of Out patients and 70% of In patients showed good improvement, 20% 
of Out & In patients showed moderate improvement, 15% of Out patient and10% In 
patients showed poor improvement was observed. 
 
 In Bio-Chemical analysis, the trial medicine contains amino acid, ferrous 
iron, starch, un saturated compounds. 
 
 Pharmacological studies of Mukkirattai Chooranam showed potent analgesic 
and anti inflammatory effects in rats. 
 
 Clinically the drug was free from side effect. 
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CHAPTER-VIII 
 
CONCLUSION 
 
 Kumba Vatham (Periarthritis) is primarily, due to derangement of 
Vatham. 
 Mukkirattai Chooranam predominating with Kaippu Suvai 
respectively neutralize the Vatham. 
 Clinical pharmacological studies which showed very good analgesic 
and anti – inflammatory activity. 
 The trial medicine do not produce any toxicity in clinical studies. So 
safe drug for prolong use to Kumba Vatham. 
 In Bio-chemical analysis the trial medicine contains amino acid,  
ferrous iron, starch, un saturated compounds.  
 No toxic effects were observed during the treatment and after the 
completion of treatment. 
 The trial medicines was reduce the symptoms of Kumba Vatham. It is 
observed only by clinical and assessment outcome. 
 The preparation of trial medicine was easy and very low cost. 
 Therefore, this clinical trial medicine Mukkiratti Chooranam should 
be a positive remedy for Kumba Vatham (Periarthritis). 
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ANNEXURE-I 
PREPARATION OF TRIAL DRUG 
LITERATURE VIEW OF TRIAL DRUG 
 
Drug  : Mukkirattai Chooranam 
Ref  : Mooligai Gunapadam Mudhal Vagappu (Page No.780) 
Ingredient : Mukkirattai leaf 
Procedure : Purified dry drug is taken and powdered and then it is filtered  
using pure white cloth and kept in air tight container. 
 
Dosage : 2 gm b.i.d. after food 
Adjuvant : Hot water 
Duration : 30 days 
Indication : Vatha disease 
 
TRIAL DRUG 
 
MUKKIRATTAI: 
 
Botanical name : Boerhavia diffusa 
Family   : NYCTAGINACEAE 
NtW ngaH  : Gl;gfk;> %f;Ful;il> ,uj;jGl;gpfh 
Rit   : ifg;G 
jd;ik  : ntg;gk; 
gphpT   : fhHg;G 
nra;if  : Nfhioafw;wp (Expectorant) 
rpWePHg; ngUf;fp (Diuretic) 
kykpsf;fp (Larative) 
FspHr;rpAz;lhf;fp (Refrigerant) 
GOf;nfhy;yp (Anthelmintic) 
the;jpAz;lhf;fp (Emetic) 
 
nghJf;Fzk; : rPj kfw;We; jpdtlf;Fq; fhe;jpjUk; 
    thj tpidia kbf;Fq;fhz; - Ngjp 
    nfhLf;Fkij cz;lhf;fhw; NfhksNk! gpj;jk; 
    mLf;FNk %f;Ful;ilaha; 
       - mfj;jpaH Fzthflk;  
ii 
 
nghUs;  : Iak;> eikr;ry;> tspg;gpzp ,itfis ePf;Fk;.  
moifAk;> fopr;riyAk;> moy; gpzpiaAk; 
cz;lhf;Fk;.  
  
    ‘%f;fpul;ilapdpiy KiwAz thj Neh 
    ahf;ifapw; ngl;b auntd; tlq;FNk” 
        - Njud; ntz;gh 
 
nghUs;  : %f;fpul;il ,iyia czT KiwahfNtDk;>  
kUj;Jt KiwahfNtDk; Grpj;J tu clypYs;s 
tsp Neha;fs; xd;We; jiyfhl;lhJ. mit 
ngl;bapw; ghk;G Nghy mlq;fptpLk;. 
  
iii 
 
ANNEXURE-II 
BIO-CHEMICAL ANALYSIS OF 
MUKKIRATTAI CHOORANAM 
 
Preparation of the extract:   
 
  5 gms of the drug was weighed accurately and placed in a 250ml clean beaker 
then 50ml of distilled water is added and dissolved well. Then it is boiled well for 
about 10 minutes. It is cooled and filtered in a 100ml volumetric flask and then it is 
made   to 100ml with distilled water.  This extract is taken for analysis. 
 
QUALITATIVE ANALYSIS 
Sl. 
No. 
EXPERIMENT OBSERVATION INFERENCE 
1.  
TEST FOR CALCIUM 
2ml of the above prepared extract is taken in a 
clean test tube. To this add 2ml of 4% 
Ammonium oxalate solution 
No white 
precipitate is 
formed. 
Absence of 
calcium 
2. 
TEST FOR SULPHATE 
2ml of the extract is added to 5% Barium 
chloride solution. 
No white 
precipitate is 
formed. 
Absence of 
sulphate 
3.  
TEST FOR CHLORIDE 
The extract is treated with silver nitrate solution 
No white 
precipitate is 
formed. 
Absence of 
chloride 
4. 
TEST FOR CARBONATE 
The extract is treated with concentrated Hcl. 
No brisk 
effervescence is 
formed. 
Absence of 
carbonate 
5. 
TEST FOR STARCH 
The extract is added with weak iodine solution 
Blue colour is 
formed 
Indicates the 
Presence of 
starch 
6.  
TEST FOR FERRIC IRON 
The extract is acidified with Glacial acetic acid 
and potassium ferro cyanide. 
No blue colour is 
formed 
Absence of 
ferric iron 
7. 
TEST FOR FERROUS IRON  
The extract is treated with concentrated Nitric 
acid and Ammonium thiocyanate solution 
Blood red colour 
is formed 
Indicates the 
presence of 
ferrous iron 
8.  
TEST FOR PHOSPHATE 
The extract is treated with Ammonium 
Molybdate and concentrated nitric acid 
No yellow 
precipitate is 
formed 
Absence of 
phosphate 
9.  
TEST FOR ALBUMIN 
The extract is treated with Esbach’s reagent 
No yellow 
precipitate is 
formed 
Absence of 
albumin 
iv 
 
10.  
TEST FOR TANNIC ACID 
The extract is treated with ferric chloride. 
No blue black 
precipitate is 
formed  
Absence of 
Tannic acid 
11.  
TEST FOR UNSATURATION 
Potassium permanganate solution is added to the 
extract 
It gets 
decolourised 
Indicates the 
presence of 
unsaturated 
compound 
12.  
TEST FOR THE REDUCING SUGAR 
5ml of Benedict’s qualitative solution is taken in 
a test tube and allowed to boil for 2 minutes and 
add 8-10 drops of the extract and again boil it 
for 2 minutes. 
No colour change 
occurs 
Absence of 
reducing 
sugar 
13.  
TEST FOR AMINO ACID 
One or two drops of the extract is placed on a 
filter paper and dried well. After drying, 1% 
Ninhydrin is sprayed over the same and dried it 
well. 
Violet colour is 
formed  
Indicates the 
presence 
amino acid 
14. 
TEST FOR ZINC 
The extract is treated with Potassium 
Ferrocyanide. 
No white 
precipitate is 
formed 
Absence of 
zinc 
 
Inference: 
 
 Indicates the Presence of amino acid, ferrous iron, starch and un starched 
compound. 
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ANNEXURE-III 
ANALGESIC ACTIVITY OF MUKKIRATTAI CHOORANAM AGAINST 
ACETIC ACID INDUCED WRITHING REFLUX IN MICE 
 
Analgesic activity of Mukkirattai Chooranam at a dose of 100 mg/kg and 
200 mg/kg was evaluated by acetic acid induced writhing reflux in mice. Painful 
reactions in animals may be produced by the chemicals such as phenylquionolone, 
bradykinin etc. Like that, acetic acid pain reaction which is characterized as a 
writhing response. Construction of abdomen, turning of trunk (twist) and extension of 
hind legs are taken as reaction to chemically induced pain. Analgesics (both narcotic 
and non-narcotic) inhibit writhing response. 
 
Requirements 
 
 Animal: Swiss albino mice (20 – 25g) either sex 
 Drugs and chemicals: Diclofenac sodium (standard), 
      Acetic acid (1%), Mukkirattai Chooranam 
Method: 
 
Treatment protocol: 
 
Group-1: Treated as normal control received 10ml/kg of normal saline through 
orally 
Group-2: Treated as standard control received 10mg/kg of diclofenac sodium 
through orally 
Group-3: Treated as Test-I received 100mg/kg of Mukkirattai Chooranam with 2 
ml of sterile water through orally 
Group- 4: Treated as Test- II received 200mg/kg of Mukkirattai Chooranam with 2 
ml of sterile water through orally 
 
Both dose of Mukkirattai Chooranam were administered one hour prior to the 
acetic acid administration. Note the onset on writhing. Record the numbers of 
abdominal contractions, trunk twist and extension of hind limbs as well as the number 
of animals showing such response during a period of 10 minutes were noted. 
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Statistics: 
 
Data are expressed as mean ± S E M; data analyzed by one way ANOVA 
followed by Dunnet’s multiple range tests to determine the significance of the 
difference between the control group and rats treated with extracts. 
* Values were considered significant at P < 0.01. 
 
ANALGESIC ACTIVITY OF MUKKIRATTAI CHOORANAM  
AGAINST ACETIC ACID INDUCED WRITHING REFLUX IN MICE 
 
 
Treatment Dose (mg/kg) 
No. of 
writhing 
% 
reduction 
in reaction 
time 
Group-I 
Normal saline 
Inject 1%v/v acetic acid 
1ml/100g of body weight 
35.2±2.6 - 
Group-II 
Standard 
10mg/kg Diclofenac 
sodium through orally 
7.5±0.7 68.70*** 
Group-III 
Mukkirattai Chooranam 
100mg/kg administered 
through orally 
10.96 ±  0.2 58.19*** 
Group-IV 
Mukkirattai Chooranam 
200mg/kg administered 
through orally 
10.4 ±0.5 67.35*** 
 
Values are expressed as mean ± S E M  
Values are analysed by one way ANOVA followed by Dunnet’s multiple range tests  
*** Values were considered significant at P < 0.001. 
 
 
Results: 
 
The table values show that analgesic activity of Mukkirattai Chooranam at a 
dose of 100mg/kg and 200mg/kg by acetic acid induced writhing reflex. The result 
reveals that both doses of Mukkirattai Chooranam possess significant analgesic 
activity at P < 0.001. 
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ANTI-INFLAMMATORY ACTIVITY 
ANTI-INFLAMMATORY ACTIVITY OF MUKKIRATTAI CHOORANAM 
AGAINST CARRAGEENAN INDUCED PAW EDEMA IN RATS 
 
The anti-inflammatory activities of Mukkirattai Chooranam at a dose of 
100mg/kg and 200mg/kg body weight were evaluated using Carrageenan induced paw 
edema method. The inflammation was readily produced in the form of edema with the 
help of the irritant such as carrageenan. Carrageenan is a sulphated polysaccharide 
obtained from sea weed (Rhodophyceae) and when injected cause the release of 
prostaglandins by the way it produces inflammation and edema. 
 
Requirements: 
 
Animal   : Albino rat (180 – 200g)  
Drugs and chemicals  : Diclofenac sodium (standard), 
               carrageenan (1%), Mukkirattai Chooranam  
     Digital plethysmometer UGO Basile (Italy) 
Method: 
 
 The animals were divided into 4 groups each having six animals 
 
Treatment protocol: 
 
Group-1: Treated as normal control received 10ml/kg of normal saline through 
orally 
Group-2: Treated as standard control received 10mg/kg of diclofenac sodium 
through orally 
Group-3: Treated as treatment control received 100mg/kg of Mukkirattai 
Chooranam  with 2 ml of sterile water through orally 
Group- 4: Treated as treatment control received 200mg/kg of Mukkirattai 
Chooranam with 2 ml of sterile water administered through orally 
 
A freshly prepared suspension of carrageenan (1% w/v, 0.1ml) was injected to 
the plantar region of left hind paw of each rat. One group was kept as control and the 
animals of the other groups were pretreated with Mukkirattai Chooranam given 
through orally 60 min before the carrageenan treatment. The paw volumes of the test 
compounds, standard and control groups were measured at 60, 120, 180 minutes of 
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carrageenan treatment with the help of Digital plethysmometer UGO Basile (Italy). 
Mean increase in paw volume was measured and the percentage of inhibition was 
calculated. 
 
% anti-inflammatory activity = (Vc – Vt/Vc) x 100 
Where Vt is  mean increase in paw volume in rats treated with test compounds  
Vc is mean increase in paw volume in control group of rats 
 
Statistics: 
 
Data are expressed as mean ± S E M; data analysed by one way ANOVA 
followed by Dunnet’s multiple range tests to determine the significance of the 
difference between the control group and rats treated with test compounds. 
 
* Values were considered significant at P < 0.01. 
 
ANTI-INFLAMMATORY ACTIVITY OF MUKKIRATTAI CHOORANAM 
AGAINST CARRAGEENAN INDUCED PAW EDEMA IN RATS 
 
Treatment Dose (mg/kg) 
Paw volume(ml) 
as measured at 3 
hour 
Percentage 
inhibition of 
paw edema 
Group-I 
Normal saline 
5ml/kg orally 4.95 ± 0.76  
Group-II 
Standard 
10mg/kg Diclofenac 
sodium through  orally 
1.48 ± 0.26 70.02** 
Group-III 
Mukkirattai 
Chooranam 
100mg/kg administered 
through orally 
3.54 ± 0.02 50.25** 
Group-IV 
Mukkirattai 
Chooranam 
200mg/kg administered 
through orally 
1.98 ± 0.95 59.91** 
 
Values are expressed as mean ± S E M  
Values are analyzed by one way ANOVA followed by Dunnet’s multiple range tests, 
to determine the significance of the difference between the control group and rats 
treated with the test compounds.  
** Values were considered significant at P < 0.01. 
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Results: 
 
 Mukkirattai Chooranam at a dose of 100 and 200mg/kg were tested for their 
anti-inflammatory activity by using carrageenan induced rat paw edema method and 
the results are tabulated in table. The results reveals that both doses of Mukkirattai 
Chooranam 100 and 200mg/kg possess significant anti-inflammatory activity when 
compared to control group at p<0.01. 
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ANNEXURE-IV 
ACUTE TOXICITY STUDY 
 
Acute oral toxicity refers to those adverse effects occurring following oral 
administration of a single dose of a substance or multiple doses given within 24 hours. 
Acute toxic class method (OECD guidelines 423, (2000) was followed to arrive at the 
maximum safety dose of the drug extracts. Three Wistar strain female albino rats (8-
12 weeks old, 180-200g body weight) were used in each group. Single dose (2g/kg) of 
the Mukkirattai Chooranam was orally administered to overnight fasted (food but not 
water withheld) animals while control animals received the vehicle (0.3%w/v CMC). 
Animals were observed individually after dosing at least once during the first 4 hrs 
and daily thereafter, for a total of 14days. Body weights of the animals were recorded. 
The other observations include changes for skin, fur, eyes and mucous membranes, 
respiratory, circulatory and autonomic and central nervous system and somatomotor 
activity and behavior pattern. At the end of 14 days, all animals were subjected to 
gross necropsy. 
 
Statistics: 
 
Data are expressed as mean ± S E M; data analysed by one way ANOVA 
followed by Dunnet’s multiple range tests to determine the significance of the 
difference between the control group and rats treated with test compounds. 
* Values were considered significant at P < 0.5. 
 
Results: 
Acute toxicity study: 
 
 All of the rats fed with the food sample showed normal general behavior, 
respiratory pattern, cardiovascular signs, motor activities, reflexes and normal change 
in skin and fur. 
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TABLE-1 
HEMATOLOGICAL VALUES OF MUKKIRATTAI CHOORANAM  
IN THE ACUTE TOXICITY STUDY 
S. 
No 
Parameter Control 
Sample 
2g/kg 
1. White blood cells (x10
3
/µl) 9.36±0.54 8.91 ±1.26 
2. Hemoglobin (g/dl) 11.50±0.26 12.95 ± 0.98 
3. Mean corpuscular volume 60.45±2.3 58.90 ± 0.51 
4. Mea corpuscular hemoglobin conc. (g/dl) 34.56±0.86 34.51 ± 1.47 
5. Platelet (x10
5
/µl ) 5.60±0.52 4.95 ± 1.03 
6. Red blood cell (x10
6
/µl ) 3.87±0.24 2.98 ± 0.29 
 
Values are expressed as Mean ± S E M 
All groups were treated with oral dose of 2g/kg body weight 
No significant different from normal control 
 
TABLE-2 
BLOOD CHEMICAL VALUES OF FOOD SAMPLE  
IN THE ACUTE TOXICITY STUDY 
S. 
No. 
Parameter Control Sample 2g/kg 
1  Glucose (mg/dl) 148.75±3.96 142.85 ± 2.19 
2  BUN (mg/dl) 34.26±1.23 31.95 ± 0.21 
3  Creatinine (mg/dl)  0.46±0.06 0.69 ± 0.14 
4  Total protein (g/dl) 5.48±0.23 4.98 ±0.04 
5  Albumin (g/dl) 3.49±0.62 2.98 ± 0.29 
6  Total bilirubin (mg/dl) 0.26±0.02 0.38 ± 0.15 
7  AST (u/l) 141.5±3.76 139.26 ± 0.29 
8  ALT (u/l) 86.36±1.75 90.51 ± 0.12 
9  ALP (u/l) 75.57±2.16 74.19 ± 0.38 
 
Values are expressed as Mean ± S E M 
All groups were treated with oral dose of 2g/kg body weight 
No significant different from normal control 
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DISCUSSION AND CONCLUSION: 
 
In acute toxicity study for 14 days, at a dose of 2g/kg of Mukkirattai 
Chooranam sample were chosen for the experiment. In the aspect of general 
behaviours, the rats treated with food sample at a single dose had no signs of behavior 
changes and toxic signs. The treated groups revealed no significant differences in 
body weight gain. The increase in body weight may have resulted from physiological 
changes in rats such as metabolism, food and water intake. However, the result from 
animal health monitoring in the entire period of 14days showed no sign of morbidity 
and diseases.  
 
The albino Wistar rats were healthy as shown by the normal appearance of 
general behavior, respiratory pattern, cardiovascular signs, motor activities, reflexes 
and normal change in skin fur. 
 
With regards to hematological values, most of values in treated groups were 
normal in comparison with the control group. Significantly, some values were 
different from those of the control group such as RBC, MCV, MCHC, and platelet. 
However, such values are within the normal ranges. These variations may have 
resulted from variation among animal groups (Feldman et al., 2000) (Inala et al., 
2002). Therefore, these results suggest that the test drug did not cause hematological 
or immunological defects in rats.  
 
Furthermore, blood chemical examination was performed in order to evaluate 
any toxic effects on liver. In this study, the levels of these blood chemical values were 
minor changes and remained within the normal range (Casley and King, 1980) 
(Levine, 1995) (Angkhasirisap et al., 2002). 
 
In conclusion, Mukkirattai Chooranam sample given orally to Wistar rats 
did not produce toxicities. 
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ANNEXURE-V 
GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE-II RANDOMIZED CLINICAL TRIAL ON 
KUMBA VATHAM (PERIARTHRITIS) WITH 
MUKKIRATTAI CHOORANAM 
FORM-I 
SCREENING AND SELECTION PROFORMA 
 
1. Name___________                   2.Age_____   3.Gender________  4.Phone no  _________ 
5. OP No.  6. IP No.                                     7. Sl. No.  . 
INCLUSION CRITERIA:  
 Age: 30 – 60 years. 
 Sex: both male and female 
 Patient having main symptoms of shoulder joint pain, radiating towards 
upper arm and forearm numbness, restricted movement of upper limb, loss 
of abduction and forwarded flexion followed by stiffness of the shoulder 
joints.  
 Patient willing to sign the informed consent stating that he / she will 
consciously stick to the treatment during 30 days. But can opt out of the 
trial of his / her own. 
 Willing for doing laboratory investigations and X-ray, imaging. 
 Diabetes mellitus. 
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EXCLUSION CRITERIA  
 Rheumatoid Arthritis. 
 Cervical spondylosis. 
 Ischemic heart diseases. 
 Systemic hypertension. 
 Pregnancy and lactation. 
 Recent shoulders dislocation. 
 
 
 
 
Date       :       
Station   : 
 
 
 
 
Signature of the Investigator: 
 
 
 
 
Signature of the Lecturer:                                            Signature of the HOD: 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE-II RANDOMIZED CLINICAL TRIAL ON 
KUMBA VATHAM (PERIARTHRITIS) WITH 
MUKKIRATTAI CHOORANAM 
FORM-IA 
CASE SHEET PROFORMA  
 
I.P. No. :    NATIONALITY :  
BED No. :                                    RELIGION  :  
WARD No. :    OCCUPATION :  
NAME :    INCOME  :  
AGE  :    D.O.A.  :  
SEX  :    D.O.D.  :  
 
PERMANENT ADDRESS:   DIAGNOSIS  :  
 
 
 
                                                                                
                                                                                
MEDICAL OFFICER  
 
 
 
COMPLAINTS AND DURATION: 
 
 
 
 
HISTORY OF PRESENT ILLNESS:  
 
 
 
HISTORY OF PAST ILLNESS:  
 
 
 
PERSONAL HISTORY & HABITS: 
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1. Diet     : Veg. / Non-Veg.  
2. Marital status   : Single / Married  
3. Emotional stress   : Yes / No  
4. Addiction    : Yes / No  
 
If yes specify   :  
 
5. Bowel habit    : Regular / Constipation  
6. Sleep    : Good / Disturbed / Insomnia  
7. Presence of anxiety   : Yes / No  
 
FAMILY HISTORY:  
 
1. Cardiovascular disease : Yes / No  
2. Tuberculosis   : Yes / No  
3. Others    : Yes / No  
If yes specify:  
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE-II RANDOMIZED CLINICAL TRIAL ON 
KUMBA VATHAM (PERIARTHRITIS) WITH 
MUKKIRATTAI CHOORANAM 
FORM-II & II-A 
CLINICAL ASSESSMENT ON ENROLLMENT AND ON VISITS 
 
1. S.No.:  _______     2. OP/IP No.: __________                            
      3.  Name: _______________________   4. Gender: __________    
5. Date of assessment: _____________  
 
GENERAL EXAMINATION:  
 
1. Physical build   : Normal / Obese  
2. Height (cm)   :  
3. Weight (kg)   :  
4. Pulse rate   :  
5. Heart rate   :  
6. Respiratory rate  :  
7. Blood pressure  :  
8. Pallor    :  
9. Cyanosis   :  
10. Jaundice   :  
11. Clubbing   :  
12. Pedal oedema   :  
13. JVP    :  
 
SYSTEMIC EXAMINATION:  
 
1. CVS    : Normal / Abnormal  
 
If abnormal,  
  
2. CNS    : Normal / Abnormal  
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If abnormal,  
 
3. Respiratory system  : Normal / Abnormal  
 
If abnormal,  
  
4. Digestive system   : Normal / Abnormal  
 
If abnormal, 
 
  
5. Urogenital system  : Normal / Abnormal  
 
If abnormal,  
  
 
CLINICAL EXAMINATION - SIDDHA ASPECTS: 
 
UDAL NILAI:  
 
1. Vatham    
2. Pitham  
3. Kapham  
4. Kalappu  
 
PARUVA KAALAM (SEASONS):  
 
1. Kaar Kaalam (Aavani-Puratasi) Aug-Sept  
2. Koothir Kaalam (Iypasi - Karthigai) Oct - Nov  
3. Munpani Kaalam (Maargazhi-Thai) Dec-Jan  
4. Pinpani Kaalam (Masi-Panguni) Feb-Mar  
5. Elavenil Kaalam (Chithirai-Vaikasi)Apr-May  
6. Mudhuvenil Kaalam (Aani-Aadi) Jun-Jul  
 
NILAM (PLACES): 
 
1. Kurinchi (Hills Areas) 
2. Mullai (Forest)  
3. Marudham (Fertile Areas)  
4. Neithal (Sea Areas)  
5. Paalai (Desert Areas)  
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IYAMPORIGAL/PULANGAL:  
 
1. Mei (Sensation)  :  
2. Vaai (Taste)   : 
3. Kann (Vision)   : 
4. Mooku (Smell)    : 
5. Sevi (Hearing)  : 
 
KANMENTHIRIYAM / KANMAVIDAYAM:  
 
1. Kai (Koduthal)  :  
2. Kaal (Nadathal)  :  
3. Vaai (Pesal)  :  
4. Eruvai (Malam kazhithal) :  
5. Karuvai (Aananthithal) :   
 
UYIR THATHUKKAL: 
 
VATHAM:       PITHAM: 
 
1. Pranan  :  1. Anala pitham :   
2. Abanan  :                       2. Ranjaga pitham : 
3. Viyanan  :  3. Saadhaga pitham :   
4. Udhanan  :   4. Aalosaga Pitham : 
5. Samanan  :                       5. Prasaga Pitham : 
6. Naagan  : 
7. Koorman  :   KAPHAM: 
8. Kirukaran  :  1. Avalambagam : 
9. Devadathan  :  2. Kledagam  : 
10. Dhananjeyan :  3. Podhagam  : 
      4. Tharpagam  :  
      5. Santhigam  :  
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UDAL THATHUKKAL:  
 
1. Saaram   :  
2. Senneer   :  
3. Oon    :  
4. Kozhuppu   :  
5. Enbu    :  
6. Moolai   :  
7. Sukkilam / Suronitham :  
 
 
ENVAGAI THERVUGAL:  
 
1. Naadi  : 
2. Sparisam  :  
3. Naa   :  
4. Niram  :  
5. Mozhi  :  
6. Vizhi 
7. Malam  : 
    a) Niram   : 
    b) Nurai   : 
    c) Erugal   :  
    d) Elagal   : 
8. Moothiram   : 
    a. Neer kuri  :  
      1) Niram   : 
      2) Edai   : 
      3) Manam   : 
      4) Nurai   : 
      5) Enjal   : 
    b. Nei kuri   : 
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NEI KURI EXAMINATION:  
 
Before treatment:                                            After treatment: 
 
 
 
 
  
SIGNS AND SYMPTOMS: 
 
PRESENT          ABSENT  
1. Pain in shoulder joints    
2. Tenderness  
3. Stiffness  
4. Difficulty to move the joint  
5. Radiating pain  
 
CLINICAL EXAMINATION OF AFFECTED JOINT 
 
INSPECTION: 
    Present   Absent 
 
 Symmetry   
 Swelling 
 Joint deformity 
 If present, _____________________  
 
 Muscle wasting 
 
 Range of motion: Affected / Not affected 
 
 
PALPATION: 
    Present   Absent 
 
 Symmetry   
 If present, _____________________  
 
 Warmth 
 Tenderness 
 Crepitation 
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MOVEMENTS: 
 
1. Restriction of movements : Full  Partial     NO 
 
2. Movements: 
 
Movements 
Pain 
Muscular 
spasm 
Range of 
movement 
Yes NO Yes NO 
N
o
rm
a
l 
R
ed
u
ce
d
 
i). Flexion       
ii). Extension       
iii). Abduction       
iv). Adduction       
v). Circumduction       
vi). Rotation        
vii). Lateral rotation (External)       
viii). Medical rotation (Internal)       
ix). Others       
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PAIN ASSESMENT 
 
OXFORD SHOULDER SCORE 
 
  
 
Please answer the following 12 multiple choice questions. 
 
 
 
 
 
 
o None 
o Mild 
o Moderate 
o Severe 
o Unbearable  
 
o Yes, easily 
o With little difficulty 
o With moderate difficulty 
o With extreme difficulty 
o No, impossible 
 
 
 
 
 
o No trouble at all  
o Little trouble 
o Moderate trouble 
o Extreme difficulty 
o Impossible to do 
 
o None 
o Very mild 
o Mild 
o Moderate 
o Severe 
 
 
 
 
 
 
 
 
 
o No trouble at all 
o Very Little trouble 
o Moderate trouble 
o Extreme difficulty 
o Impossible to do 
 
 
o Yes, easily 
o With little difficulty 
o With moderate difficulty 
o With great difficulty 
o No, impossible 
 
 
 
 
 
o Yes, easily 
o With little difficulty 
o With moderate difficulty 
o With extreme difficulty 
o No, impossible 
 
o Yes, easily 
o With little difficulty 
o With moderate difficulty 
o With extreme difficulty 
o No, impossible 
 
  
1. How would you describe the worst  
     pain you had from your shoulder? 
7. Could you brush/comb your hair with  
    the affected arm? 
2. Have you had any trouble dressing  
    yourself because of your shoulder? 
8. How would you describe the pain you  
    usually had from your shoulder? 
3. Have you had any trouble getting in  
   and out of a car or using public  
   transport because of your shoulder? 
9. Could you hand your clothes up in a  
   wardrobe, using the affected arm?  
    (Whichever you tend to use) 
4. Have you been able to do your daily  
    activities all at the same time? 
10. Have you been able to wash and dry  
      yourself under both arms? 
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o Yes, easily 
o With little difficulty 
o With moderate difficulty 
o With extreme  difficulty 
o No, impossible 
 
o Not at all 
o A little bit 
o Moderately 
o Greatly 
o Totally 
  
 
 
 
o Yes, easily 
o With little difficulty 
o With moderate difficulty 
o With great difficulty 
o No, impossible 
o No nights 
o Only 1 or 2 nights 
o Some nights 
o Most nights 
o Every night 
 
 
 The oxford Shoulder Score is: 48 
 
Interpreting the Oxford Shoulder Score 
 
Score   0 to  19 Indicate sever shoulder arthritis 
Score   20 to 29 Indicate moderate to severe 
Score   30 to 39 Indicate mild to moderate 
Score  40 to 48 Indicate satisfactory joint function 
 
                Before treatment               After treatment 
 
 
 
 
 
 
Date       :       
Station   : 
Signature of the Investigator: 
Signature of the Lecturer      :                                         
 
 
         
        Signature of the HOD 
5. Could you do the household  
    shopping on your own? 
11. How much has pain from your  
      shoulder interfered with your usual  
      work (including housework)? 
6. Could you carry a tray containing a  
    plate of food across a room? 
12. Have you been troubled by pain  
    from your shoulder in bed at night? 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE-II RANDOMIZED CLINICAL TRIAL ON 
KUMBA VATHAM (PERIARTHRITIS) WITH 
MUKKIRATTAI CHOORANAM 
FORM-III 
LABORTORY INVESTIGATIONS 
 
1. S.No.:  _______     2. OP/IP No.: __________                            
      3.  Name: _______________________   4. Gender: __________    
5. Date of assessment: _____________  
INVESTIGATION 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
TC   
DC   
Hb gms%   
ESR: 
     30 mints 
     60 mints 
  
Blood Sugar : 
     Fasting 
     Postprandial 
  
S.Cholesterol   
B. Urea   
B.Creatinine   
Uric acid   
RA factor   
Urine: 
     Albumin 
     Sugar 
     Deposit 
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SPECIFIC INVESTIGATION:  
 
X-Ray of affected shoulder joint (AP and lateral view) 
ECG for some selected cases (R/O Ischemic heart disease) 
 
 
 
 
 
 
 
 
 
  
 
   Medical Officer Signature:  
Prof.  / H.O.D  
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE-II RANDOMIZED CLINICAL TRIAL ON 
KUMBA VATHAM (PERIARTHRITIS) WITH 
MUKKIRATTAI CHOORANAM 
FORM-IV 
 
CONSENT FORM 
 
 
I certify that I have disclosed all the details about the study in the terms readily 
understood by the patient.  
 
 
 
Date :       Signature:  
Name: 
 
CONSENT BY THE PATIENT 
 
I have been informed to my satisfaction by the attending physician for the 
purpose of the clinical trial and the nature of the drug treatment and follow up 
including the lab investigation to be performed to monitor and safeguard my body 
functions.  
 
I am aware of my right to opt out of the trial at any time during the course of 
the trial without having to give reasons for doing so.  
 
I, exercising my free power of choice, here by give my consent to be included 
as a subject in the clinical trial of MUKKIRATTAI CHOORANAM for the 
treatment of KUMBAVATHAM.  
 
Date:      Signature: ………………………………… 
Name: ……………………………………. 
       Signature of Witness: ……………………. 
Name………….. …………………………   
                                                                        Relationship: ……………………………. 
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muR rpj;j kUj;Jtf; fy;Y}hp kw;Wk; kUj;Jtkid> 
ghisaq;Nfhl;il> jpUney;Ntyp khtl;lk;. 
 
gl;lNkw;gbg;G nghJ kUj;Jtj;Jiw 
 
Fk;gthj Neha;f;F kUe;jhf  
%f;fpul;ilr; #uzk; 
 
ghpfhpg;Gj; jpwidf; fz;lwpAk; kUj;Jt Ma;T xg;Gjy; gbtk; 
 
Ma;thshpd; rhd;wpjo; 
 
 ehd; ,e;j Ma;T Fwpj;j midj;J tpguq;fisAk; Nehahspf;Fg; GhpAk; 
tifapy; vLj;Jiuj;Njd; vd cWjpaspf;fpNwd;. 
 
 
 
       ifnahg;gk; 
       ngaH:  
Njjp : 
,lk; : 
 
Nehahspapd; xg;Gjy; 
 
 vd;dplk; ,e;j kUj;Jt Ma;tpd; fhuzj;ijAk;> kUe;jpd; jd;ik 
kw;Wk; kUj;Jt topKiwiag; gw;wpAk; njhlHe;J vdJ cly; ,af;fj;ij 
fz;fhzpf;fTk;> mjidg; ghJfhf;fTk; gad;gLk; kUj;Jt Ma;Tf; $l 
ghpNrhjidfs; gw;wp jpUg;jp mspf;Fk; tifapy; Ma;T kUj;Jtuhy; tpsf;fpf; 
$wg;gl;lJ. 
 ehd; ,e;j kUj;Jt Ma;tpd;NghJ fhuzk; vJTk; $whky; vg;nghOJ 
Ntz;LkhdhYk; ,e;j Ma;tpypUe;J vd;id tpLtpj;Jf; nfhs;Sk; 
chpikia njhpe;jpUf;fpNwd;.  
 ehd; vd;Dila Rje;jpukhf NjHT nra;Ak; chpikiaf; nfhz;L 
Fk;gthj Neha;f;F kUe;jhf %f;fpul;ilr; #uzk; ghpfhpg;Gj; jpwidf; 
fz;lwpAk; kUj;Jt Ma;tpw;F vd;id cl;gLj;j xg;Gjy; mspf;fpNwd;. 
 
 
 
       ifnahg;gk; 
       ngaH:  
Njjp : 
,lk; : 
 
       rhl;rpapd; ifnahg;gk; 
       ngaH: 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE-II RANDOMIZED CLINICAL TRIAL ON 
KUMBA VATHAM (PERIARTHRITIS) WITH  
MUKKIRATTAI CHOORANAM 
FORM-IV A 
 
WITHDRAWAL FORM 
 
 
Name: ________________________       OPD/ IPD number: __________ 
Age   : ________      
Date of trial commencement: ___________ 
Date of withdrawal from trial: ___________ 
Reasons for withdrawal: 
 Long absence at reporting   :  Yes                No 
 Irregular treatment    : Yes                 No 
 Shift of locality    : Yes                 No 
 Increase in severity of symptoms  : Yes                 No 
 Development of severe adverse drug reactions: Yes                 No 
Date : 
Station :     
 
 
Signature of Investigator     Signature of HOD 
          
                      
 
 
Signature of Lecturer 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE-II RANDOMIZED CLINICAL TRIAL ON 
KUMBA VATHAM (PERIARTHRITIS) WITH  
MUKKIRATTAI CHOORANAM 
FORM-IV B 
 
PATIENT INFORMATION SHEET 
 
 It is a inflammatory disorder. 
 This disease is not contagious. 
 It cause painful shoulder, stiffness, tenderness, difficulty in moving the 
shoulder joint. 
 Many herbal and mineral siddha medicines are currently practiced by the 
siddha practitioners for this disease. 
 The trial drug is prescribed only with evidence of Siddha literature. 
 The trial drug is prepared at the Gunapadam Lab of Government Siddha 
Medical College & Hospital, Palayamkottai under the direct supervision of 
teaching faculties of Maruthuvam and Gunapadam Department. 
 
Details of the trial drug: 
   Drug  : Mukkirattai Chooranam 
   Dose  : 2 gms; twice a day. 
   Adjuvant : Hot water 
   Duration : 30 days.   
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murpdH rpj;j kUj;Jtf; fy;Y}hp kw;Wk; kUj;Jtkid> 
ghisaq;Nfhl;il> jpUney;Ntyp khtl;lk;. 
 
gl;lNkw;gbg;G nghJ kUj;Jtj;Jiw 
 
%f;fpul;ilr; #uzj;jpd; ghpfhpg;Gj; jpwidf;  
fz;lwpAk; kUj;Jt Ma;T jfty; gbtk; 
 
 Fk;gthj NehahdJ %l;Lf;fspy; cs;s jir ehHfspy; tPf;fj;ij 
Vw;gLj;jf; $baJ.  
 ,e;NehahdJ  Njhs;gl;il %l;Lf;fspy; typ> tpiug;Gj;jd;ik> 
%l;Lf;fis nray;gLj;Jtjpy; rpukk; Mfpa FwpFzq;fis 
Vw;gLj;Jk;. 
 rpj;j kUj;Jtj;jpy; mjpf msT %ypiffs; kw;Wk; jhJg; nghUl;fs; 
,e;Neha;f;F kUe;jhfg; gad;gLfpwJ. 
 Vw;fdNt cgNahfj;jpy; cs;s ,J Nghd;w kUe;J ,Jtiu 
Nehahspfsplk; ve;jtpj gf;f tpisTfis Vw;gLj;jtpy;iy.  
 ,e;j kUe;J rpwg;ghf Fk;gthj Neha;f;fhf mq;fPfhpf;fg;gl;l rpj;j 
kUj;Jt E}ypy; ngwg;gl;Ls;sJ. 
 Nkw;fz;l kUe;jhdJ murpdH rpj;j kUj;Jtf; fy;Y}hp kw;Wk; 
kUj;Jtkid> ghisaq;Nfhl;ilapy; cs;s gl;lNkw;gbg;G Fzg;ghlk; 
kUe;J nra; Ma;tfj;jpy; nra;J Kbf;fg;gl;lJ. 
 ,e;j Muha;r;rp rk;ge;jkhf rpy Nfs;tpfisf; Nfl;fTk;> Njitahd 
Ma;tf ghpNrhjidf;Fj; jq;fis cl;gLj;jTk; cs;Nsd;.  
 ,J rk;ge;jkhf jq;fsJ midj;J tpguq;fSk; ufrpakhf 
itf;fg;gLk; vd;W cWjpaspf;fpNwd;. 
 ,e;j Muha;r;rpapd; NghJ clYf;F NtW ghjpg;G Vw;gLk;gl;rj;jpy; 
murpdH rpj;j kUj;Jtf; fy;Y}hp kw;Wk; kUj;Jtkid> 
ghisaq;Nfhl;ilapy; jf;f rpfpr;ir mspf;fg;gLk;. 
 ,e;j Muha;r;rpapy; NrHe;j gpwF cq;fSf;F tpUg;gk; ,y;iynadpy; 
vg;nghOJ Ntz;LkhdhYk; tpyfp nfhs;syhk;. 
 NkYk; ,e;j Muha;r;rpf;F IEC mDkjpr; rhd;W ngwg;gl;Ls;sJ.  
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE-II RANDOMIZED CLINICAL TRIAL ON 
KUMBA VATHAM (PERIARTHRITIS) WITH  
MUKKIRATTAI CHOORANAM 
FORM–IV C 
 
ADVERSE DRUG REACTION FORM 
 
 
 
Name: ________________________       OPD/ IPD No: __________ 
Age: ________      
Date of trial commencement: ___________ 
Date of withdrawal from trial: ___________ 
Description of adverse reaction: 
____________________________________________________________________ 
____________________________________________________________________ 
 
Date : 
Station :     
 
 
 
 
 
Signature of Investigator     Signature of HOD 
          
                      
 
 
 
 
Signature of Lecturer 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE-II RANDOMIZED CLINICAL TRIAL ON 
KUMBA VATHAM (PERIARTHRITIS) WITH  
MUKKIRATTAI CHOORANAM 
FORM-IV D 
 
DISCHARGE CASE SHEET PROFORMA 
 
 
I.P. No.  :   Occupation   :  
Bed No.  :   Income   :  
Ward No.  :   Nationality   :  
Name    :   Religion   :  
Age / Sex  :   Date of Admission :   
Address  :   Date of Discharge :  
Diagnosis  :  
No. of Days treated :  
 
 
 
 
 
CLINICAL PROGNOSIS: 
 
 
AT THE TIME OF 
ADMISSION 
AT THE TIME OF 
DISCHARGE 
  
 
 
 
 
Medical Officer Signature:  
PROF / H.O.D  
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE-II RANDOMIZED CLINICAL TRIAL ON 
KUMBA VATHAM (PERIARTHRITIS) WITH  
MUKKIRATTAI CHOORANAM 
FORM-IV E 
DRUG COMPLIANCE FORM 
 
 
Name of The Drug : MUKKIRATTAI CHOORANAM 
Drugs issued date :  
Drugs returned date : 
Days DATE 
DRUG TAKEN TIME 
MORNING TIME EVENING TIME 
Day 1    
Day 2    
Day 3    
Day 4    
Day 5    
Day 6    
Day 7    
Day 8    
Day 9    
Day 10    
Day 11    
Day 12    
Day 13    
Day 14    
Day 15    
           Name : _____________________ Age/ Sex : ___________     S. No : _________ 
          OPD/ IPD No : ____________ Date       : ___________   Bed No : _________  
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Day 16    
Day 17    
Day 18    
Day 19    
Day 20    
Day 21    
Day 22    
Day 23    
Day 24    
Day 25    
Day 26    
Day 27    
Day 28    
Day 29    
Day 30    
 
 
 
 
 
 
Date : 
Station :     
 
 
 
 
 
Signature of Investigator     Signature of HOD 
          
 
 
 
                    
 
 
Signature of Lecturer 
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